<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_PJs7dA8">Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials</title>
				<funder ref="#_CxtbDyX #_E4rEQgh">
					<orgName type="full">EU</orgName>
				</funder>
				<funder ref="#_PmaFskV #_RpyZfnR #_MXJcVzt #_EbMgCQH #_54T4FhR #_k8AcUYB #_dYRBU4x #_gjeWcp4 #_ue6jNmG #_qSehPFr #_a4vW3gv #_FECzsFR #_hDD7q2E #_dJHDG3W #_P7rpWbY #_HtqwfxB #_cSayV6q">
					<orgName type="full">unknown</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.</p>
				</availability>
				<date type="published" when="2023-03-05">5 March 2023</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Prof</roleName><forename type="first">George</forename><surname>Moschonis</surname></persName>
							<email>g.moschonis@latrobe.edu.au</email>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">George</forename><surname>Siopis</surname></persName>
							<email>george.siopis@deakin.edu.au</email>
						</author>
						<author>
							<persName><forename type="first">Jenny</forename><surname>Jung</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Evette</forename><surname>Eweka</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Ruben</forename><surname>Willems</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Dominika</forename><surname>Kwasnicka</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yeboah-Asiamah</forename><surname>Bernard</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Vimarsha</forename><surname>Asare</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nick</forename><surname>Kodithuwakku</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rajesh</forename><surname>Verhaeghe</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lieven</forename><surname>Vedanthan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Brian</forename><surname>Annemans</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yannis</forename><surname>Oldenburg</surname></persName>
						</author>
						<author>
							<persName><surname>Manios</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Eweka</forename><surname>Ba</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">R</forename><surname>Vedanthan</surname></persName>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="first">N</forename><surname>Verhaeghe</surname></persName>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="first">Kodithuwakku</forename><surname>Mhhsm</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">B</forename><surname>Oldenburg</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Department of Food, Nutrition and Dietetics , School of Allied Health , Human Services and Sport (Prof G Moschonis PhD , G Siopis PhD) and Academic and Research Collaborative in Health (Prof B Oldenburg PhD) , La Trobe University , Melbourne , VIC , Australia;</note>
								<orgName type="department" key="dep1">Department of Food, Nutrition and Dietetics</orgName>
								<orgName type="department" key="dep2">School of Allied Health</orgName>
								<orgName type="department" key="dep3">Human Services and Sport (Prof G Moschonis PhD</orgName>
								<orgName type="department" key="dep4">G Siopis PhD) and Academic and Research Collaborative in Health (Prof B Oldenburg PhD)</orgName>
								<orgName type="institution">La Trobe University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country>Australia;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Institute for Physical Activity and Nutrition , School of Exercise and Nutrition Sciences , Deakin University , Geelong , VIC , Australia</note>
								<orgName type="department" key="dep1">Institute for Physical Activity and Nutrition</orgName>
								<orgName type="department" key="dep2">School of Exercise and Nutrition Sciences</orgName>
								<orgName type="institution">Deakin University</orgName>
								<address>
									<settlement>Geelong</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>(</label> G Siopis); Maternal , Child and Adolescent Health Program , Burnet Institute , Melbourne , VIC , Australia (J</note>
								<orgName type="department" key="dep1">G Siopis); Maternal</orgName>
								<orgName type="department" key="dep2">Child and Adolescent Health Program</orgName>
								<orgName type="institution">Burnet Institute</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC (J</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Jung MIPH) ; Department of Population Health , NYU Grossman School of Medicine , New York , NY , USA</note>
								<orgName type="department" key="dep1">Jung MIPH)</orgName>
								<orgName type="department" key="dep2">Department of Population Health</orgName>
								<orgName type="institution">NYU Grossman School of Medicine</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">Department of Public Health and Primary Care , Faculty of Medicine , Ghent University , Ghent , Belgium</note>
								<orgName type="department" key="dep1">Department of Public Health and Primary Care</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Prof L Annemans PhD) ; Research Institute for Work and Society , HIVA KU Leuven , Leuven , Belgium (</note>
								<orgName type="department" key="dep1">Prof L Annemans PhD)</orgName>
								<orgName type="department" key="dep2">Research Institute for Work and Society</orgName>
								<orgName type="institution">HIVA KU Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">Prof N Verhaeghe) NHMRC CRE in Digital Technology to Transform Chronic Disease Outcomes , Baker Heart and Diabetes Institute , Melbourne , VIC , Australia</note>
								<orgName type="department">Digital Technology to Transform Chronic Disease Outcomes</orgName>
								<orgName type="institution" key="instit1">Prof N Verhaeghe) NHMRC CRE</orgName>
								<orgName type="institution" key="instit2">Baker Heart and Diabetes Institute</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<note type="raw_affiliation">Curtin School of Population Health , Curtin University , Perth , WA , Australia</note>
								<orgName type="department">Curtin School of Population Health</orgName>
								<orgName type="institution">Curtin University</orgName>
								<address>
									<settlement>Perth</settlement>
									<region>WA</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<note type="raw_affiliation">Department of Nutrition and Dietetics , School of Health Science and Education , Harokopio University , Athens , Greece (</note>
								<orgName type="department" key="dep1">Department of Nutrition and Dietetics</orgName>
								<orgName type="department" key="dep2">School of Health Science and Education</orgName>
								<orgName type="institution">Harokopio University</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<note type="raw_affiliation">Prof Y Manios PhD) ; Institute of Agri-food and Life Sciences , Hellenic Mediterranean University Research Centre , Heraklion , Greece</note>
								<orgName type="department" key="dep1">Prof Y Manios PhD)</orgName>
								<orgName type="department" key="dep2">Institute of Agri-food and Life Sciences</orgName>
								<orgName type="institution">Hellenic Mediterranean University Research Centre</orgName>
								<address>
									<settlement>Heraklion</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<note type="raw_affiliation">Institute for Physical Activity and Nutrition , School of Exercise and Nutrition Sciences , Deakin University , Burwood , VIC 3125 , Australia</note>
								<orgName type="department" key="dep1">Institute for Physical Activity and Nutrition</orgName>
								<orgName type="department" key="dep2">School of Exercise and Nutrition Sciences</orgName>
								<orgName type="institution">Deakin University</orgName>
								<address>
									<postCode>3125</postCode>
									<settlement>Burwood</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<note type="raw_affiliation">Department of Food, Nutrition and Dietetics , School of Allied Health , Human Services and Sport , La Trobe University , Melbourne , VIC 3086 , Australia</note>
								<orgName type="department" key="dep1">Department of Food, Nutrition and Dietetics</orgName>
								<orgName type="department" key="dep2">School of Allied Health</orgName>
								<orgName type="department" key="dep3">Human Services and Sport</orgName>
								<orgName type="institution">La Trobe University</orgName>
								<address>
									<postCode>3086</postCode>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_KpbRgVb">Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2023-03-05">5 March 2023</date>
						</imprint>
					</monogr>
					<idno type="MD5">CB202B453FD0CA2916820F849163B6B0</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T11:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_SDFDAat"><p xml:id="_bFEcSED"><s xml:id="_yrja94t">Background Digital health interventions have shown promising results for the management of type 2 diabetes, but a comparison of the effectiveness and implementation of the different modes is not currently available.</s><s xml:id="_GKN5NFM">Therefore, this study aimed to compare the effectiveness of SMS, smartphone application, and website-based interventions on improving glycaemia in adults with type 2 diabetes and report on their reach, uptake, and feasibility.</s><s xml:id="_JE99xfw">Methods In this systematic review and meta-analysis, we searched CINAHL, Cochrane Central, Embase, MEDLINE, and PsycInfo on May 25, 2022, for randomised controlled trials (RCTs) that examined the effectiveness of digital health interventions in reducing glycated haemoglobin A 1c (HbA 1c ) in adults with type 2 diabetes, published in English from Jan 1, 2009.</s><s xml:id="_jVh5qqv">Screening was carried out using Covidence, and data were extracted following Cochrane's guidelines.</s><s xml:id="_sXC52M6">The primary endpoint assessed was the change in the mean (and 95% CI) plasma concentration of HbA 1c at 3 months or more.</s><s xml:id="_m5UJ8nq">Cochrane risk of bias 2 was used to assess risk of bias.</s><s xml:id="_Vjg7bWF">Data on reach, uptake, and feasibility were summarised narratively and data on HbA 1c reduction were synthesised in a meta-analysis.</s><s xml:id="_69BrEjw">Grading of Recommendations, Assessment, Development, and Evaluation criteria was used to evaluate the level of evidence.</s><s xml:id="_4vh2PC7">The study was registered with PROSPERO, CRD42021247845.</s><s xml:id="_4MGjmdR">Findings Of the 3236 records identified, 56 RCTs from 24 regions (n=11 486 participants), were included in the narrative synthesis, and 26 studies (n=4546 participants) in the meta-analysis.</s><s xml:id="_4pvTefR">20 studies used SMS as the primary mode of delivery of the digital health intervention, 25 used smartphone applications, and 11 implemented interventions via websites.</s><s xml:id="_a6rTSz7">Smartphone application interventions reported higher reach compared with SMS and website-based interventions, but website-based interventions reported higher uptake compared with SMS and smartphone application interventions.</s><s xml:id="_DpQSszq">Effective interventions, in general, included people with greater severity of their condition at baseline (ie, higher HbA 1c ) and administration of a higher dose intensity of the intervention, such as more frequent use of smartphone applications.</s><s xml:id="_8kQu8vN">Overall, digital health intervention group participants had a -0•30 (95% CI -0•42 to -0•19) percentage point greater reduction in HbA 1c , compared with control group participants.</s><s xml:id="_Vs3Njvx">The difference in HbA 1c reduction between groups was statistically significant when interventions were delivered through smartphone applications (-0•42% [-0•63 to -0•20]) and via SMS (-0•37% [-0•57 to -0•17]), but not when delivered via websites (-0•09% [-0•64 to 0•46]).</s><s xml:id="_AaeRa7Z">Due to the considerable heterogeneity between included studies, the level of evidence was moderate overall.</s><s xml:id="_QtBExSA">Interpretation Smartphone application and SMS interventions, but not website-based interventions, were associated with better glycaemic control.</s><s xml:id="_2QcUAzP">However, the studies' heterogeneity should be recognised.</s><s xml:id="_ZJFx6W7">Considering that both smartphone application and SMS interventions are effective for diabetes management, clinicians should consider factors such as reach, uptake, patient preference, and context of the intervention when deciding on the mode of delivery of the intervention.</s><s xml:id="_33RWhv6">Nine in ten people worldwide own a feature phone and can receive SMS and four in five people have access to a smartphone, with numerous smartphone applications being available for diabetes management.</s><s xml:id="_AG3vCrf">Clinicians should familiarise themselves with this modality of programme delivery and encourage people with type 2 diabetes to use evidence-based applications for improving their self-management of diabetes.</s><s xml:id="_7JJrnjJ">Future research needs to describe in detail the mediators and moderators of the effectiveness and implementation of SMS and smartphone application interventions, such as the optimal dose, frequency, timing, user interface, and communication mode to both further improve their effectiveness and to increase their reach, uptake, and feasibility.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Nu6pqj2">Introduction</head><p xml:id="_vkUmC33"><s xml:id="_jnwpySZ">Type 2 diabetes affects an estimated half a billion people worldwide, <ref type="bibr" target="#b4">1</ref> with a cost in excess of US$1•3 trillion per annum. <ref type="bibr" target="#b5">2</ref> The risk of adverse outcomes in people with type 2 diabetes and the cost of managing this condition can be reduced by lowering blood glucose levels, in addition to correcting hypertension and dyslipidaemia. <ref type="bibr" target="#b6">3</ref></s><s xml:id="_Dgms59k">urrent guidelines recommend that adults with type 2 diabetes should reach a glycated haemoglobin A 1c (HbA 1c ) of less than 7•0% (53 mmol/mol) as part of their glycaemic control. <ref type="bibr" target="#b7">4</ref></s><s xml:id="_22ve8zS">elf-management, education and support have been recommended to enhance individuals' knowledge, skills, and the tools needed for the successful sustainable control of their clinical condition. <ref type="bibr" target="#b8">5</ref></s><s xml:id="_rKp55Ma">Digital health interventions present a feasible and effective means of type 2 diabetes self-management. <ref type="bibr" target="#b9">[6]</ref><ref type="bibr" target="#b10">[7]</ref></s><s xml:id="_5hDVZQj">7]<ref type="bibr" target="#b11">[8]</ref> Since the introduction of the first smartphone in 1994, <ref type="bibr" target="#b12">9</ref> mobile phones have rapidly evolved to allow for a plethora of diverse capabilities to facilitate health education and support of self-management.</s></p><p xml:id="_JxzWnXa"><s xml:id="_J6Dmtue">As of January, 2023, 6•92 billion people in the world (86%) have access to a smartphone, and another 410 million people use a conventional mobile phone, accounting together for 92% of the global population. <ref type="bibr" target="#b13">10</ref></s><s xml:id="_t9cdYVj">elehealth can also be more convenient and accessible than traditional face-to-face health-care delivery, because it can be delivered synchronously or asynchronously. <ref type="bibr" target="#b14">11</ref></s><s xml:id="_TcjTyer">ynchronous refers to the delivery of health information in real time (eg, via a telephone call) and asynchronous refers to the store-and-forward technique of health infor mation-ie, the transmission of health information from the health-care provider to a patient (eg, via SMS).</s><s xml:id="_DQAgvz6">Synchronous interventions can use telephone or video-conference calls as well as mobile phone applications that collect clinical data, such as blood glucose or blood pressure, and transmit these in real time allowing for the health-care professional to provide prompt advice about titrating and adjusting medications such as insulin. <ref type="bibr" target="#b15">12</ref></s><s xml:id="_Y56ZQ8p">Synchronously delivered social media interventions can also use online forums in which patients can engage with peers, discuss the challenges they are facing, and interact with health-care professionals in real time, facilitating the identification of barriers and enablers to successful glycaemic control. <ref type="bibr" target="#b15">12</ref></s><s xml:id="_Y8SpNuR">synchronous interventions use SMS to reinforce appropriate behavioural changes-eg, performing adequate physical activity, eating a sufficient amount of vegetables, or using online tools that provide general condition-specific education. <ref type="bibr" target="#b15">12</ref></s><s xml:id="_8CcjC6e">revious reviews have highlighted key determinants of the effectiveness of digital health interventions such as education, feedback, and communication between health-care provider and patient, <ref type="bibr" target="#b16">13</ref> but these reviews did not compare the effectiveness of different synchronous and asynchronous digital health intervention tools such as SMS, smartphone applications, and website-based tools. <ref type="bibr" target="#b17">[14]</ref><ref type="bibr" target="#b18">[15]</ref></s><s xml:id="_XVnChMb">]<ref type="bibr" target="#b19">[16]</ref><ref type="bibr" target="#b20">[17]</ref><ref type="bibr" target="#b21">[18]</ref> To our knowledge, this systematic literature review and meta-analysis is the first to synthesise and compare the current evidence on the effectiveness and implementation of different modes of digital health interventions in adults with type 2 diabetes.</s><s xml:id="_JSNM936">Our research question was how do smartphone applications, SMS, and websitebased interventions compare in terms of their reach, uptake and feasibility, and their effectiveness in reducing HbA 1c in people with type 2 diabetes during the past thirteen years (2009-22)?</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_89ER4hc">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2swwwwa">Search strategy and selection criteria</head><p xml:id="_5qFXsWR"><s xml:id="_vHphBtC">The protocol and reporting of this systematic review and meta-analysis were consistent with the 2020 PRISMA guidelines. <ref type="bibr" target="#b22">19</ref></s><s xml:id="_nGkT25E">APA PsycInfo, CINAHL Complete, Cochrane Central Register of Controlled Trials, Ovid Embase, and Ovid MEDLINE were searched on May 25, 2022, using broad search terms and MeSH terms.</s><s xml:id="_skxxYtG">The search strategy was optimised to capture studies in people with type 2 diabetes and hypertension using search terms such as "type 2 diabetes", "t2d", "t2dm", "diabetic", "high blood glucose", "hypertension", "high blood pressure", and "hypertensive".</s><s xml:id="_TuRqkXW">The complete search strategy is in the appendix (pp 2-7).</s><s xml:id="_s8KwYDY">Due to the volume of data, and to allow an in-depth discussion, the findings in people with hypertension are reported in a separate manuscript. <ref type="bibr" target="#b23">20</ref></s><s xml:id="_QGScW6M">In addition to the database searches, we hand-searched the reference lists of reviews of digital health interventions.</s></p><p xml:id="_bwAYPWV"><s xml:id="_RNvKuSf">Citations and abstracts of all retrieved studies were imported into Covidence systematic review software (Veritas Health Innovation, Melbourne, Australia).</s><s xml:id="_5vb4h45">Duplicates were removed and the remaining studies were assessed for inclusion by two researchers (GS and JJ).</s><s xml:id="_EFvcjnc">The full list of inclusion and exclusion criteria is in the appendix (p 8).</s><s xml:id="_ywP92Ky">Briefly, randomised controlled trials (RCTs), cluster RCTs, pilot RCTs, crossover RCTs, and prospective RCTs of type 2 diabetes management programmes in adults, implementing digital health interventions and published in English from Jan 1, 2009, to May 25, 2022, (the date that the last searches were conducted) were considered for inclusion.</s><s xml:id="_5BYPWSj">Any type of digital health intervention, except for telecounselling or telemonitoring, was eligible for inclusion.</s><s xml:id="_nMCJgC3">Trials were excluded if the control group or groups received substantial intervention using digital tools (appendix p 8).</s><s xml:id="_zBnsFWN">To reflect current practice, only contemporary publications after 2009 were considered, because that was when digital health applications started to become widely adopted. <ref type="bibr" target="#b24">21</ref></s><s xml:id="_7jqxmGp">The systematic review protocol was registered in PROSPERO, CRD42021247845.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Zx73gP7">Data extraction</head><p xml:id="_mHmZYRb"><s xml:id="_4hCa3bC">A comprehensive data extraction form was developed (GS) and refined (GS and JJ) based on the guidelines in the Cochrane Handbook for Systematic Reviews of Interventions. <ref type="bibr" target="#b25">22</ref></s><s xml:id="_HKSNPT6">The form was piloted on a subset of the included studies to ensure reliability and reproducibility, and then the following were extracted from all included studies (GS, JJ, and EE): publication details (title, journal, year); authors' details (names, affiliations, funding, conflict of interest); study details (start and end date, country, design, purpose, blinding and randomisation method, retention rate, statistical analyses); participants' characteristics (condition, severity of condition, comorbidities, inclusion criteria, exclusion criteria, sample size, recruitment process, and demographics [ie, age, sex, race, ethnicity, income, education, and remoteness of residence]); intervention (type, duration, frequency, other details, primary and secondary outcome factors); comparison (details of care and other details); results (timepoint for follow-up, primary and secondary outcomes [with standard deviations, standard errors of means, 95% CIs, and statistical significance], and the validated tool for measurement); and conclusions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_m5H3mCQ">Evidence and outcomes</head><p xml:id="_ATKujbU"><s xml:id="_j8QDrzG">The evidence was summarised in tables including the relevant study characteristics, the intervention and comparator treatments, the purpose of the intervention, and their outcomes.</s><s xml:id="_QSTgexY">The primary endpoint was the change in the mean (and 95% CI) plasma concentration of HbA 1c at 3 months or more.</s><s xml:id="_G26CuEH">For the purposes of the evaluation of effectiveness, an intervention was classified as effective if the digital health intervention resulted in statistically significant (p&lt;0•05) or clinically meaningful results (defined as a reduction in HbA 1c of ≥0•5%), or both, <ref type="bibr" target="#b26">23</ref> as compared to the control group.</s><s xml:id="_9qFR8zG">The intervention was classed as not effective if there were no statistically or clinically meaningful difference, between the groups for the outcome(s).</s><s xml:id="_zvSSRJK">Secondary endpoints of interest included blood pressure, plasma lipid profile (ie, total cholesterol, HDL and LDL cholesterol, and triglycerides), fasting plasma glucose, changes in medication, and anthropometric outcomes (eg, BMI, bodyweight, and waist circumference).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sQRGctn">Quality assessment of included studies</head><p xml:id="_hKuwt8D"><s xml:id="_xhKeCeF">The revised Cochrane risk-of-bias version 2 tool was used to assess the quality of the studies on aspects of selection (random sequence generation and allocation concealment); performance and detection (masking of participants, personnel, and assessors; deviations from intended interventions; missing outcome data; and measurement of the outcome); appropriateness of analysis (selection of the reported outcome); and bias arising from period and carryover effects (for crossover studies). <ref type="bibr" target="#b27">24</ref></s><s xml:id="_jp9m5Ek">The pertinent versions of the tool were used to appraise the quality in included RCTs, cluster RCTs, and</s></p><p xml:id="_95GCWyJ"><s xml:id="_GvF9f6b">See Online for appendix For the systematic review protocol see <ref type="url" target="https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021247845">https://www.crd.  york.ac.uk/prospero/display_  record.php?ID=CRD42021247845</ref> For more on the Cochrane riskof-bias version 2 tool see <ref type="url" target="https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials">https://methods.cochrane.org/  bias/resources/rob-2-revised- cochrane-risk-bias-tool- randomized-trials</ref> crossover trials.</s><s xml:id="_nax5KYA">Studies were ranked by three authors (GS, JJ and EE) as low risk, some concerns, or high risk.</s><s xml:id="_yhPRYnp">Authors resolved discrepancies by discussion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HaESDE9">Meta-analysis</head><p xml:id="_tR2ZCM8"><s xml:id="_ZhVzuJQ">Within-group difference in means for HbA 1c and their SDs for intervention and control groups were entered into Review Manager v5.4.1 software (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen).</s><s xml:id="_AuqWfsC">To increase the precision of the point estimate, when only between-group and not withingroup differences were reported, the latter were requested from the authors.</s><s xml:id="_3gB2vgE">If SE was reported instead of SD, then this was converted to SD using the formula: SD = SE × √n.</s><s xml:id="_5jgJdYS">If 95% CI was reported instead of SD or SE, then the SD was calculated as described in chapter 7.7.3.2 of Cochrane's handbook. <ref type="bibr" target="#b28">25</ref></s><s xml:id="_vfT32q4">Studies that did not report SD, SE, or 95% CI (and the authors of which did not respond to our request to obtain these values) were excluded from the metaanalysis.</s><s xml:id="_Y2uBNya">The effect sizes and SDs of the studies were pooled using the random-effects model.</s><s xml:id="_eEDj3Zr">The randomeffects meta-analysis model was selected, despite resulting in wider CIs around point esti mates, because heterogeneity was expected due to the differences in study populations and procedures. <ref type="bibr" target="#b29">26</ref></s><s xml:id="_cQytBmK">The robustness of the estimate was assessed via a series of sensitivity analyses that included sequentially removing each study and reanalysing the remaining datasets to identify if a single study was responsible for the direction of associations, and by testing whether the fixed-effects model would produce different results, as per the guidelines in chapter 9.7 of Cochrane's handbook. <ref type="bibr" target="#b28">25</ref></s><s xml:id="_MmA8KJN">he assumption of homogeneity of true effect sizes was assessed by the Cochran's Q test, and the degree of inconsistency across studies (I²) was calculated. <ref type="bibr" target="#b30">27</ref></s><s xml:id="_bQyUabV">² describes the percentage of total variation across studies that is due to heterogeneity rather than sampling error and ranges between 0% (no inconsistency) and 100% (high heterogeneity) with values of 0-40% suggesting low heterogeneity, 30-60% moderate heterogeneity, 50-90% substantial heterogeneity, and 75-100% considerable heterogeneity. <ref type="bibr" target="#b28">25,</ref><ref type="bibr" target="#b30">27</ref></s><s xml:id="_9F8655f">Subgroup analyses per mode of intervention were carried out to assess possible causes of heterogeneity.</s></p><p xml:id="_cnzfT7d"><s xml:id="_nqFuZbg">Publication bias was assessed by visually inspecting a funnel plot of the mean change in HbA 1c plotted against the corresponding SE, on the assumption that interventions with HbA 1c reductions and with larger samples were more likely to be published. <ref type="bibr" target="#b28">25</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VYc9EGd">Quality assessment of the overall evidence</head><p xml:id="_YJ2Casv"><s xml:id="_JVsWvhH">The quality of the overall evidence was assessed using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria. <ref type="bibr" target="#b31">28</ref></s><s xml:id="_JsrRJyV">Briefly, GRADE evaluates the type of evidence, risk of bias, consistency between studies, directness to the research question, and precision of the estimate.</s><s xml:id="_AB3quQf">All 26 studies included in the meta-analysis were given an initial score of +4 for quality of evidence, because observational studies were excluded.</s><s xml:id="_dnjtacg">Risk of bias was assessed as explained and in accordance with the recommendations of the Cochrane Collaboration. <ref type="bibr" target="#b25">22</ref></s><s xml:id="_NKHGCmB">Serious risk of bias (eg, absence of appropriate randomisation) resulted in loss of a point.</s><s xml:id="_ppbNADg">Inconsistency (eg, due to substantial heterogeneity [I²&gt;50%]), also incurred a negative point. <ref type="bibr" target="#b32">29</ref></s><s xml:id="_BnCP96n">mprecision (eg, when the 95% CI of the pooled effect overlapped the line of no effect) also downgraded the quality of evidence total score by a point. <ref type="bibr" target="#b33">30</ref></s><s xml:id="_dSnb9AK">The final GRADE score was the sum of all eight categories of evidence (risk of bias, inconsistency, indirectness, imprecision, publication bias, large effect, dose response, and all plausible residual confounding).</s><s xml:id="_gmQJm5Z">Quality of evidence was classified as high (≥4 points overall), moderate (3 points), low (2 points), or very-low quality evidence (≤1; appendix p 9). <ref type="bibr" target="#b34">31</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vZZN5p6">Evaluation of reach, adoption or uptake, and feasibility of interventions</head><p xml:id="_hHMFkCp"><s xml:id="_MbkNZKR">We also extracted and synthesised data related to reach, adoption or uptake, and feasibility of interventions (BY-AA and VK), from those studies that reported relevant information.</s><s xml:id="_dZ2YJWk">In line with the Medical Research Council process evaluation framework, we defined reach as the intended audience who came into contact with the intervention. <ref type="bibr" target="#b35">32</ref></s><s xml:id="_5ZvCqQq">Feasibility was defined as the capability of carrying out an intervention or programme, and was measured in terms of acceptability, adherence, likelihood of cost-effectiveness, or capacity of providers to deliver the intervention. <ref type="bibr" target="#b36">33</ref></s><s xml:id="_QqATkwH">We relied on authors' interpretations to report if the study was feasible or not based on specific aspects measured.</s><s xml:id="_NtYyyTk">Based on the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework, adoption or uptake was defined as reported action of taking up or making use of the intervention or health promotion programme. <ref type="bibr" target="#b37">34,</ref><ref type="bibr" target="#b38">35</ref></s><s xml:id="_hdNYxw5">For this analysis, we considered reach and adoption or uptake at the individual intervention participant level.</s><s xml:id="_4TwJTqH">Studies using different frameworks were included, when their definitions were not considerably different from the previously mentioned.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jupvYtq">Role of the funding source</head><p xml:id="_uHmX4BP"><s xml:id="_p4UMA2M">The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yMb5wJq">Results</head><p xml:id="_XsbKhJ7"><s xml:id="_sBnysXF">The database search yielded 3229 records and a further 13 records were identified after searching the reference lists of relevant systematic reviews.</s><s xml:id="_b7UNgfs">After removing 1060 duplicates, 2182 abstracts were assessed for eligibility (figure <ref type="figure">1</ref>); 1973 abstracts were excluded along with 13 records that did not have full texts.</s><s xml:id="_uQkxTWu">111 full-text articles were excluded, and reasons for exclusion are listed in the appendix (pp 10-18).</s><s xml:id="_BXeaVNn">After removing 29 additional studies that focused exclusively on people with hypertension (these data will be reported elsewhere <ref type="bibr" target="#b23">20</ref> ), 56 studies reporting the effectiveness of interventions in people with type 2 diabetes were included in the systematic review,  and 26 studies were included in the meta-analysis.</s></p><p xml:id="_w2eRSEj"><s xml:id="_ufBJcg9">From the 56 studies, 11 486 participants from 24 regions were included (table <ref type="table">1</ref>).</s><s xml:id="_eXFuKdu">Most studies were conducted in China (n=11) and the USA (n=10; appendix p 48).</s><s xml:id="_3unmn4F">All six continents were represented in this systematic review, albeit not equally, with Asia contributing 33 studies and the Americas another 13.</s><s xml:id="_b5anx5A">Five studies took place in Europe, two in Africa, and three in Oceania.</s><s xml:id="_U45Khn5">28 studies were conducted in high-income economies, 17 in uppermiddle-income econ omies, and 11 in lower-middleincome economies, according to the World Bank classification. <ref type="bibr" target="#b97">94</ref></s><s xml:id="_JYgJkjm">41 studies were conducted from 2016 and after, and 15 between 2009 and 2015.</s><s xml:id="_udN8fqw">All studies were RCTs, with 45 employing a parallel group design, two being cluster, three pilot, and six prospective (appendix pp 49-50).</s><s xml:id="_v88Wuhr">20 studies used SMS as the primary mode of delivery of the digital health intervention, <ref type="bibr" target="#b39">[36]</ref><ref type="bibr" target="#b40">[37]</ref><ref type="bibr" target="#b41">[38]</ref><ref type="bibr" target="#b42">[39]</ref><ref type="bibr" target="#b43">[40]</ref><ref type="bibr" target="#b44">[41]</ref><ref type="bibr" target="#b45">[42]</ref><ref type="bibr" target="#b46">[43]</ref><ref type="bibr" target="#b47">[44]</ref><ref type="bibr" target="#b48">[45]</ref><ref type="bibr" target="#b49">[46]</ref><ref type="bibr" target="#b50">[47]</ref><ref type="bibr" target="#b51">[48]</ref><ref type="bibr" target="#b52">[49]</ref><ref type="bibr" target="#b53">[50]</ref><ref type="bibr" target="#b54">[51]</ref><ref type="bibr" target="#b55">[52]</ref><ref type="bibr" target="#b56">[53]</ref><ref type="bibr" target="#b57">[54]</ref><ref type="bibr" target="#b58">[55]</ref> 25 used smartphone applications,  and 11 used websites. <ref type="bibr" target="#b86">[83]</ref><ref type="bibr" target="#b87">[84]</ref></s><s xml:id="_CtMcGH2">4]<ref type="bibr" target="#b88">[85]</ref><ref type="bibr" target="#b89">[86]</ref><ref type="bibr" target="#b90">[87]</ref><ref type="bibr" target="#b91">[88]</ref><ref type="bibr" target="#b92">[89]</ref><ref type="bibr" target="#b93">[90]</ref><ref type="bibr" target="#b94">[91]</ref><ref type="bibr" target="#b95">[92]</ref><ref type="bibr" target="#b96">[93]</ref> Interventions varied to align with the purpose of each study (appendix pp 19-47). SMS i</s><s xml:id="_ezZByhz">erventions delivered educational messages to increase participants' literacy on aspects of their condition and the importance of lifestyle modifications such as physical activity and diet, promote medication adherence, provide reminders for regular self-monitoring of blood glucose levels or blood pressure, and increase medication adherence and adjustment (eg, titration of insulin doses).</s><s xml:id="_bYx4CFZ"><ref type="bibr" target="#b47">44</ref> Behaviour change models (eg, the transtheoretical model) were employed to promote motivation.</s><s xml:id="_aRY2eHu"><ref type="bibr" target="#b48">45</ref> Studies that included immigrants adjusted SMS to the language of participants.</s><s xml:id="_Ycrqkn6"><ref type="bibr" target="#b41">38</ref> Other studies personalised content to the demographics of participants (eg, education status 39 and ethnicity).</s><s xml:id="_mW4N8Sz"><ref type="bibr" target="#b43">40</ref> SMS frequency ranged from daily to weekly.</s></p><p xml:id="_T6dDDYK"><s xml:id="_4z5PVfh">Smartphone applications were also used for education, 56 but due to the capabilities of modern smartphones, applications included additional features that enabled telemonitoring and communication between participants and health-care professionals as well as participant group chats.</s><s xml:id="_YdUPAtY">Some studies offered free-of-charge feedback ad libitum via the application. <ref type="bibr" target="#b59">56</ref></s><s xml:id="_2RvWPHH">Several application interventions required participants to regularly self-monitor their blood glucose levels or blood pressure, and to log these values, along with their food intake, physical activity, and medication, allowing health-care professionals to provide real-time advice for medication adjustment and tips for lifestyle modifications.</s><s xml:id="_NCVQgBT">To allow this real-time monitoring and advice, most application interventions included one or more telemonitoring devices such as external or inbuilt accelerometers, but also ingestible sensors, and adhesive wearable sensor patches. <ref type="bibr" target="#b65">62</ref></s><s xml:id="_YpmXnBK">Bluetooth technology was also used for communication between different wearable sensors and the application. <ref type="bibr" target="#b66">63</ref></s><s xml:id="_dbpxEJ5">few studies assessed the effect of applications alone, compared with application plus telemonitoring, on relevant clinical parameters. <ref type="bibr" target="#b64">61</ref></s><s xml:id="_PA6ZCXx">Other applications included sending alerts to physicians, with atypical readings triggering prompt intervention. <ref type="bibr" target="#b79">76</ref></s><s xml:id="_Sax8qZv">Teleconsultations were facilitated by inbuilt features such as voice, video, picture, or SMS. <ref type="bibr" target="#b80">77</ref></s><s xml:id="_wdyFcGq">Effective interventions that used diet logs incorporated culturally adjusted food databases that 3242 records identified 800 Cochrane Central 1054 Cinahl 851 Embase 510 MEDLINE 14 PsycInfo 13 from hand-searching reference lists 6 for hypertension 7 for type 2 diabetes 2182 titles and abstracts screened 1060 duplicate records removed 209 articles included for full-text screening 196 full texts were screened 82 studies* (85 full texts †) were included in the systematic review 56 studies (58 full texts) in people with type 2 diabetes* ‡ 29 studies (30 full texts) in people with hypertension* 26 studies included in meta-analysis in people with type 2 diabetes 1973 records excluded 505 ineligible participants 389 ineligible intervention 888 ineligible outcomes 191 ineligible study design 13 records excluded because they did not have full texts 111 full texts excluded 31 ineligible population 20 ineligible intervention 50 ineligible outcomes 9 ineligible study design 1 retracted article 30 studies excluded from meta-analysis in people with type 2 diabetes because data was not available in the format required Figure 1: Study selection *Three studies included participants with type 2 diabetes and hypertension.</s><s xml:id="_ktWHZVt">†Three studies' results were reported in two manuscripts.</s><s xml:id="_euhd6jG">‡The included studies in people with hypertension are reported in a separate manuscript. 20</s><s xml:id="_bYhTaCf">Study design; duration; number of participants; retention Intervention Outcomes Primary Secondary Characteristics of included studies that incorporated SMS interventions Abaza et al (2017), 36 Egypt RCT; 12 weeks; 90; 81% Daily SMS on diet, physical activity, complications, reminder prompts to test and record; 12 SMS from each category (84 in total); booklet of diabetes care instructions ΔHbA 1c -1•679% (intervention) and -1•389% (control; p=0•406) ΔBGL -19 mg/dL (control) and -61 mg/dL (intervention; p=0•288); Δbodyweight -0•5 kg (control) and -1•3 kg (intervention; p=0•215) Argay et al (2015), 37 Hungary Prospective RCT; 12 months; 131; 94% Medication reminders three times per day; SMS could be customised ΔHbA 1c -0•06% (intervention) and -0•4% (control; p=0•212) None Arora et al (2014), 38 USA RCT; 6 months; 218; 72% Daily SMS in English or Spanish with educational and motivational content, medication reminders, and healthy living challenges ΔHbA 1c -1•05% (intervention) and -0•6% (control; p=0•230) Medication adherence of Δ=1•1 (95% CI 0•1 to 2•1); percentage using emergency services 35•9% (intervention) and 51•6% (control); percentage who used primary care 56•3% (intervention) and 53•1% (control) Capozza et al (2015), 39 USA RCT; 180 days; 93; 60% Daily diabetes-related SMS written at fifth-grade reading level; weekly reminders to monitor blood pressure; web-based portal with stored responses No statistically significant ΔHbA 1c between intervention and control (p&gt;0•05) Mean total satisfaction score of 27•77 (SD 3•85); patients identified as Spanish had difficulty with patient interaction Dobson et al (2020), 40 New Zealand RCT; 9 months; 366; 80% Two unidirectional SMS per week automated for motivation, diabetes education, and lifestyle; messages were personalised by demographic factors (Māori and non-Māori), personal goals, and preferences ΔHbA 1c -0•9% (intervention) and -0•1% (control; p&lt;0•0001) None Fang et al (2018), 41 China RCT; 12 months; 129; 84% Appointment reminders and health information (prepared by a nurse or a doctor) sent by microletter and SMS; topics on T2D, CVD risk factors, diabetes complications and risks, frequency of blood glucose self-monitoring, reducing carbohydrate consumption, significance of BMI, and need for regular physical activity ΔHbA 1c -0•41% (intervention) and 0•09% (control; p=0•034) FPG (p=0•007), postprandial plasma glucose (p&lt;0•001), fasting insulin (p=0•004), postprandial insulin (p&lt;0•001), total cholesterol (p&lt;0•001) and LDL (p&lt;0•001) decreased significantly in intervention group but SBP decreased significantly in the control group only (p=0•014) Fortmann et al (2017), 42 USA RCT; 6 months; 126; 90% Daily culturally adapted educational and motivational SMS with medication reminders, BGL monitoring prompts; study coordinator contacted anyone who did not send BGL for 1 week ΔHbA 1c -1% (intervention) and 0•2% (control; p=0•03) 96% reported intervention helped management a lot; 97% would recommend the intervention to friend or family member with T2D Goodarzi et al (2012), 43 Iran RCT; 3 months; 81; 81% Four SMS per week on diet, physical activity, medication, and self-monitoring of BGL ΔHbA 1c -0•89% (intervention) and -0•35% (control; p=0•024) Intervention compared with control, significantly improved LDL (p=0•019), cholesterol (p=0•002), blood urea nitrogen (p≤0•001), micro albumin (p≤0•001), knowledge (p≤0•001), practice (p≤0•001), and self-efficacy (p≤0•001) Shariful Islam et al (2015), 48 Bangladesh Prospective RCT; 6 months; 236; 85% Daily SMS based on the principles of behavioural learning theory; an SMS delivery manager website was created, and SMS were delivered in partnership with Grameenphone Bangladesh ΔHbA 1c -0•85% (intervention) and -0•18% (control; p&lt;0•0001) Medication adherence decreased significantly in both groups with no significant difference between groups Kim et al (2010), 44 South Korea RCT; 12 weeks; 100; 92% Internet-based diabetes patient management system using daily SMS that produces automatic adjustment of insulin dose based on BGL; orientation on insulin, physical activity, dietary advice from an endocrinologist, nurse, dietitian, and pharmacist ΔHbA 1c -2•4% (intervention) and -2•0% (control; p=0•023); percentage with HbA 1C &lt;7% was 25•5•% (intervention) and 15•6% (control; p=0•235) Δbodyweight +2•4 kg (intervention) and +2•2 kg (control; p=0•653); no change between groups in incidence of hypoglycaemia; FBG and postprandial BGL declined earlier in the intervention vs control group Lim et al (2011), 45 South Korea RCT; 6 months; 103; 94% Medical instructions given via mobile phone; glucometer that automatically transfers results to hospital-based server, then system sends automatic patient-specific SMS ΔHbA 1C -0•4% (intervention) and 0•1% (control; p=0•274) Percentage with HbA 1C &lt;7% without hypoglycaemia 30•6% (intervention) and 14•0% (control; p&lt;0•05) Peimani et al (2016), 49 Bahrain RCT; 3 months; 250; 100% Tailored SMS group and non-tailored SMS group; the tailored group received 75% of messages tailored to top two barriers reported in survey or scale; the non-tailored group received random messages regardless of barriers; SMS provided education on diet, physical activity, BGL monitoring and medication adherence ΔHbA 1C -0•23% (tailored SMS), -0•27% (non-tailored SMS), and 0•03% (control; p=0•19) Mean Self-Care Inventory scores significantly increased and mean Diabetes Self-Care Barriers and Diabetes Management Self-Efficacy Scale scores significantly decreased in both tailored and non-tailored SMS groups Ramallo-Fariña et al (2020), 46 Spain* Cluster RCT; 24 months; 2334; 72% Eight educational sessions (one every 3 months); monitoring of physical activity, diet, drug adherence, mood, BP, and BGL; weekly access to a website and tailored feedback by semiautomated SMS based on results from website, focusing on education and behaviour modification ΔHbA 1c at month 6 -0•26 (95% CI 0•44 to 0•08) in favour of intervention None Sadanshiv et al (2020), 47 India RCT; 3 months; 320; 95% Automatic SMS based on transtheoretical model of behavioural change with educational content regarding healthy eating habits and physical activity; two messages per week for 3 months ΔHbA 1c -0•48 in favour of intervention (p&lt;0•001) ΔBMI -0•6 in favour of intervention (p&lt;0•001); 96% of intervention group received regular messages, of which 93% read the messages and 80% acted on them; 93% felt satisfied with their health care (Table 1 continues on next page) Study design; duration; number of participants; retention Intervention Outcomes Primary Secondary (Continued from previous page) Shetty et al (2011), 50 India Pilot RCT; 12 months; 215; 67% One SMS every 3 days on principles of diabetes management (eg, diet, physical activity, medication reminders, and lifestyle); SMS contents and frequencies varied as per the patients' preferences No significant difference in HbA 1C decrease between groups FPG (p&lt;0•002) and 2 h PG (p&lt;0•002) decreased significantly in the SMS group Tamban et al (2014), 51 Philippines RCT; 6 months; 104; 79% Three SMS per week in Filipino (Mondays was about diet, Wednesdays was about exercise, and Fridays was about consequences of not adhering to diabetes management); SMS was evaluated by endocrinologist and a diabetes educator after which a focus group discussion was facilitated by the primary investigator among ten diabetes patients to determine if the SMS could be easily understood ΔHbA 1c -0•47% (intervention) and -33% (control; p=0•034) Significant difference in favour of intervention for mean number of meals per day (p=0•018) and mean number of minutes per exercise (p=0•021) Vinitha et al (2019), 52 India RCT; 24 months; 248; 88% Educatory SMS (2-3 times a week) on healthy lifestyle practices and adherence to medication; tailored advice on diet and physical activity ΔHbA 1c 2•1% (intervention) and -1•7% (control; p=0•044) ΔFPG and ΔBP, significantly lower (p=0•007) in intervention vs control group; significant reduction in total calorie and fat intake in both groups Wargny et al (2018), 53 Senegal Crossover RCT; 3 months; 186; 97% Two centres (S and P) served as intervention and control by time randomisation; intervention received daily SMS during the first three months then no SMS; same SMS series (50 SMS overall) were sent to each intervention group ΔHbA 1c month 0 to 3 -0•4% (intervention [S]) and +0•2% (control [P]; p=0•0038); ΔHbA 1c month 3 to 6 -0•2% (control [S]) and +0•1% (intervention [P]) Campaign cost US$3•1 per person Whittemore et al (2020), 54 Mexico Pilot RCT; 6 months; 85; 94% Seven interactive group-based educational sessions (tailored socioculturally); daily text or picture messages to promote behaviour change; education on physical activity, stress management, medication adherence, prevention of complications, and on nutrition (based on the smart plate) ΔHbA 1c -1•77% (intervention) and -0•96% (control; p=0•11) Group-by-time effects seen in SMBG and diabetes self-efficacy; time effects for intervention group including improved self-care behaviour (diet, physical activity, SMBG), self-efficacy and depressive symptoms; time effects for control group including improved physical activity, SMBG, and depressive symptoms Xu et al (2020), 55 USA RCT; 6 months; 65; 57% Two to three SMS per week; self-reporting of FPG by responding to automated telephone calls or SMS; high FPG triggered automated alert via text or telephone call to the provider for possible acute event, and the platform issued an automated instruction directly to patients to contact their providers or call 911, or both; messages written at fourth grade level ΔHbA 1c -0•69% (intervention) and -0•03% (control; p=0•055) ΔFPG -21•6 mg/dL (intervention) and +13•0 mg/dL (control; p=0•946); response rate 63•6% (intervention) and 64•9% (control); engagement rate 58% (intervention) and 48% (control) Characteristics of included studies that incorporated smartphone app interventions Omar et al (2020), 56 United Arab Emirates RCT; 6 months; 218; 75% Structured education via WhatsApp as per the American Association of Diabetes Educators Self-Care Behaviours recommendations; daily messages contained information about healthy eating, food portions, physical activity, self-monitoring of BGL, reminders for medication intake, and insulin use; participants could seek advice and get free-of-charge feedback via the app ΔHbA 1c -0•7% (intervention) and -0•1% (control; clinically significant) Patient satisfaction: 90% of patients reported preference to continue social media intervention, 80% said it was beneficial, and 67% found it convenient Anzaldo-Campos et al (2016), 57 Mexico RCT; 10 months; 202; 90% Interactive surveys; SMS, short educational videos through a mobile phone app; the interactive survey was designed to promote tracking and accountability; participants received a MyGlucoHealth glucose meter, glucose test strips, and a 3G-enabled mobile phone ΔHbA 1c -3•0% (intervention) and -1•3% (control; p=0•009) Intervention significantly improved diabetes knowledge compared with control (p 0•05) Bender et al (2017), 58 USA Pilot crossover RCT; 3 months; 45; 100% Accelerometer to self-monitor physical activity real time (steps); associated app with diary to self-report daily food intake and weekly weight; study's private Facebook group for virtual support, coaching, and weekly education topics posted by research staff Opposing and mixed patterns were displayed in the HbA 1c outcomes Attendance at all seven intervention office visits was 95% (intervention) and 100% (control); in both phases, group receiving intervention displayed improved values for step counts, bodyweight, BMI and, waist circumference Chao et al (2019), 59 China RCT; 18 months; 121; 98% Mobile app to facilitate pre-intervention and post-intervention assessments and behaviour changes Intervention improved ΔHbA 1c significantly (p=0•02) more than control (no values reported) 86% of participants improved health knowledge through mobile app Dong et al (2018), 60 China RCT; 12 months; 121; 98% Health education via WeChat; bidirectional ΔHbA 1c -2•92% (intervention) and -0•88% (control; p&lt;0•05) No significant difference of FPG and 2 h PG concentrations were found between intervention and control (p&gt;0•05) Franc et al (2020), 61 France RCT; 12 months; 434; 100% Intervention groups: app only; app and telemonitoring; smartphone app that incorporates patient data and calculates insulin dose; data are sent every 2 h to a platform which is monitored by nurse and the investigator; automatic messages containing analytical data produced daily ΔHbA 1c -0•20% (control) -0•34% (app only), and -0•26% (app and telemonitoring; comparable between arms) Post-hoc analysis in participants using the app ≥1 times per day showed significant reduction (app only vs control, p=0•001; app and telemonitoring vs control p≤0•001); no significant differences between groups for symptomatic hypoglycaemia (p=0•129) (Table 1 continues on next page) Articles e132 <ref type="url" target="www.thelancet.com/digital-health">www.thelancet.com/digital-health</ref></s><s xml:id="_mjTm32j">Vol 5 March 2023 Study design; duration; number of participants; retention Intervention Outcomes Primary Secondary (Continued from previous page) Frias et al (2017), 62 USA Prospective pilot cluster RCT; 12 weeks; 109 with both T2D and HTN; 91% Smartphone app; ingestible sensor-adhesive wearable sensor patch; provider web portal; feedback for medication taking and other health behaviours to both patients and providers ΔHbA 1c -0•19 (intervention) and +0•26% (control); ΔHbA 1c intervention -control -0•48% (95% CI -1•04 to -0•09%) ΔSBP -21•8mm Hg (intervention) and -12•7 mm Hg (control); ΔSBP intervention-control -9•1 mm Hg (95% CI -14•5 to -3•3); percentage of participants that achieved BP goal was 80•0% (intervention) and 51•7% (control); difference=28•3% Gong et al (2020), 63 Australia RCT; 12 months; 187; 87% Smartphone app for personalised support, monitoring, and motivational coaching via a conversational agent; access to website; blood glucose meter with Bluetooth; brief, structured interactions with a programme coordinator ΔHbA 1c -0•33% (intervention) and -0•28% (control; p=0•03) None Gunawardena et al (2019), 64 Sri Lanka RCT; 6 months; 67; 78% Android-based Smart Glucose Manager app that provides medication and BGL monitoring reminders, and prompts for healthy eating and physical activity ΔHbA 1c -2•32% (intervention) and -1•27% (control; p&lt;0•0001) None Hilmarsdóttir et al (2021), 65 Iceland RCT; 6 months; 37; 81% Smartphone app with digital lifestyle programme (gamified technology) to enhance lifestyle change; healthy behaviours are rewarded health points that mount up and result in water donations to UNICEF as an extra reward ΔHbA 1c -0•7% (intervention) and -0•1% (control; p=0•190) None Kleinman et al (2016) 66 and Kleinman et al (2017), 67 India RCT; 6 months; 91; 89% Smartphone app and web portal for T2D management, informed by theories of behaviour change; provided reminders, data visualisation, and ongoing support to increase self-care behaviours and assist collaborative care decisions ΔHbA 1c -1•5% (intervention) and -0•8% (control; p=0•02) Medication adherence was 39•0% (intervention) and 12•8% (control; p=0•03); frequency of BGL self-testing was 39•0% (intervention) and 10•3% (control; p=0•01); 80% were satisfied with app Ku et al (2020), 68 South Korea Pilot RCT; 12 weeks; 40; 88% Smartphone app for weight control and dietary management; logging diet to calculate dietary intake using a database of local foods; &gt;3•7 million food options and 50 000 Korean food items, updated by registered nutritionist; colour coding (red, yellow, and green) to help healthier food choice; pedometer % achieving target HbA 1c 47•1% (intervention) and 11•1% (control; p=0•019) Summary of Diabetes Self-Care Activities questionnaire showed improvement in both groups (except for exercise) with no difference between groups other than foot care (p=0•008) Kumar et al (2021), 69 India RCT; 6 months; 300; 100% Smartphone app focusing on lifestyle modification and medication management; app also answered frequently asked questions and provided tips and references ΔHbA 1c -0•26% (intervention) and +0•13% (control; p=0•01) None Lee et al (2020), 70 South Korea RCT; 6 months; 140; 92% Smartphone app and individualised feedback messages from health-care professionals for diabetes self-management education; medical information was entered to the mobile app and shared through social network services ΔHbA 1c 0•1% (control) and -0•3% (intervention; p=0•05) None Li et al (2021), 71 China Prospective RCT; 6 months; 101; 84% Smartphone app to display exercise videos; wearable chest band to monitor heart rate, exercise duration and intensity ΔHbA 1c -0•55% (intervention) and -0•70% (control; p&gt;0•05) Change in body fat percentage was -1•8% (intervention) and -0•8% (control; p=0•01) Lu et al (2021), 72 China RCT; 6 months; 120; 99% WeChat for medication alarm clock, medication guidance, and automatic drug instruction query; in-hospital pharmacy consultation and medication evaluation, and drug reorganisation with medical monitoring and advice ΔHbA 1c -1•77% (intervention) and -1•03% (control; p=0•002) ΔFBG was -1•68 mmol/L (intervention) and 1•01 mmol/L (control; p=0•077) Or et al (2020), 73 Hong Kong RCT; 24 weeks; 299 with both T2D and HTN; 97% Smartphone app to record BP and blood glucose via Bluetoothconnected monitors; data accessible by health professionals via web portal; education for the prevention of T2D and HTN, selfcare, diet, exercise, health plans, and stress management ΔHbA 1c -0•45% (intervention) and -0•35% (control; p=0•52) ΔSBP was +0•5 mm Hg (intervention) and -2•8 mm Hg (control; p=0•10); ΔDBP -0•1 mm Hg (intervention) and -0•5 mm Hg (control; p=0•73) Quinn et al (2016), 74 USA Cluster RCT; 12 months; 118; retention not reported Smartphone app for patient coaching and provider clinical decision support; patients entered diabetes self-care data on a mobile phone and receive automated, real-time messages Aged ≥55 years group ΔHbA 1c -1•8% (intervention) and -0•3% (control; p=0•001); aged &lt;55 years group ΔHbA 1c -2•0% (intervention) and -1•0% (control; p=0•02); no significant difference between two age groups (p=0•44) None Sun et al (2019), 75 China RCT; 6 months; 91; retention not reported App-based diet management software to input daily dietary intake; dietitian analysed this dietary record and provided oncemonthly dietary recommendations; physical activity information (daily calorie expenditure) was obtained from participants in intervention group via text message, followed by guidance related to aerobic and resistance-based exercises; participants given glucometers capable of data transmission ΔHbA 1c -0•87% (intervention) and -0•70% (control; p=0•25) None (Table 1 continues on next page) Articles <ref type="url" target="www.thelancet.com/digital-health">www.thelancet.com/digital-health</ref></s><s xml:id="_ztSXr2F">Vol 5 March 2023 e133 Study design; duration; number of participants; retention Intervention Outcomes Primary Secondary (Continued from previous page) Waki K et al (2014), 76 Japan RCT; 12 weeks; 54; 100% Smartphone app for self-management diabetes control; app monitors health data including BGL, BP, bodyweight, and step counts; atypical readings trigger intervention by physician; participants can record physical activity and diet and receive feedback ΔHbA 1c -0•4% (intervention) and +0•1% (control; p=0•015) Change in fasting blood sugar -5•5 mg/dL (intervention) and +16•9 mg/dL (control; p=0•019) Wang et al (2019), 77 China RCT; 6 months; 120; 100% Smartphone app for health monitoring (BGL, diet, insulin and related drug use, and physical activity) followed by relevant physician recommendation; voice, picture, video, or text messages to facilitate teleconsultations ΔHbA 1c -1•50% (intervention) and -0•76% (control; p&lt;0•05) ΔFBG -3•23 mmol/L (intervention) and -1•25 mmol/L (control; p&lt;0•05); Δ in postprandial BGL -4•34 mmol (intervention) and -2•34mmol (control; p&lt;0•05); disease awareness levels 1•28 (intervention) and 71•34 (control; p&lt;0•05); selfmanagement abilities 9•14 (intervention) and 7•81 (control; p&lt;0•05) Yu et al (2019), 78 China RCT; 24 weeks; 185; 87% Intervention groups were SMBG (B), app only (C), and app and SMBG (D); smartphone app for diabetes education, selfmanagement, patient community, and real-time communication between patients and clinicians; SMBG group received blood glucose meter and strips ΔHbA 1c -1•1% (control), -1•1% (B), -1•1% (C), and -1•1% (D; p&gt;0•005) Percentage that achieved HbA 1c &lt;7%: 25•5% (A), 44•4% (B), 60•4% (C), and 62•2% (D) Yun et al (2020), 79 South Korea RCT; 12 weeks; 106 with both T2D and HTN; 76% Smartphone app for patient self-assessment, self-planning, selflearning, and self-monitoring by automatic feedback; patients created own health management weekly plan and monitored their progress on vegetable and fruit intake, physical activity, and medication ΔHbA 1c -0•71% (intervention) and -0•22% (control; p=0•014) ΔSBP in patients with HTN -17•5 mm Hg (intervention) and -11•6mm Hg (p=0•41); % that met target clinical indicators for HTN was 72•7% (intervention) and 35•7% (control; p=0•035); ΔLDL (patients with high LDL) was -23•7 mg/dL (intervention) and -25•3 mg/dL (control; p=0•72) Zhang et al (2019) 80 and Zhang et al (2019), 81 China Prospective RCT; 6 months; 234; 83% Intervention groups were self-management with smartphone app for diabetes-related knowledge and skills, including glycaemic control, diet, exercise, medication, and the use of insulin (A); and as in A plus online interactive management with a dietitian and a health manager (A+) ΔHbA 1c -2•03% (control), -1•37% (A), and -2•03% (A+; A+ vs control p=0•01; A+ vs A p=0•01); ΔFPG 8•91(control), 9•08 (A), and 7•87 (A+; A+ vs control p=0•02; A+ vs A p&lt;0•01) ΔHDL 1•20 (control), 1•16 (A), and 1•20 (A+; all p&lt;0•05) Zhou et al (2016), 82 China RCT; 3 months; 100; 100% Smartphone app that stores self-care data (BGL, carbohydrate intake, medications, and other diabetes management information) for diabetes management ΔHbA 1c -1•95% (intervention) and -0•79% (control; p&lt;0•001) ΔFBG -1•89 mmol/L (intervention) and -0•95 mmol/L (control; p&lt;0•05); SBP -2•0 mm Hg (intervention) and -0•6 mm Hg control; (p&gt;0•05) Characteristics of included studies that incorporated website-based interventions Hansel et al (2017), 83 France RCT; 16 weeks; 120; 89% Online dietetic tool for personalised menus and daily or weekly shopping list; human contact limited to hotline support in cases of technical issues; prescription of physical activity ΔHba 1c -0•37% (intervention) and +0•23% (control; p&lt;0•001) Change in dietary score +4•55 (intervention) and -1•68 (control; p=0•28); Δbodyweight-2•9 kg (intervention) and +0•2 kg (control: p&lt;0•01) Heisler et al (2019), 84 USA RCT; 6 months; 290; 82% Tailored, interactive web-based tool for diabetes education, assessment of barriers to treatment adherence, and goal setting and coaching; peer mentors followed up with weekly computerfacilitated calls ΔHba 1c at 6 months -0•70% (intervention) and -0•68% (control; not significant); ΔHba 1c at 12 months -0•56% (intervention) and -0•52% (control; not significant) No significant changes in BP Jaipakdee et al (2015), 85 Thailand RCT; 6 months; 403; 94% Computer-assisted instruction for diabetes education and lifestyle change; nurses helped participants define goals and develop action plan ΔHba 1c -0•4% (intervention) and -0•3% (control; p=0•334); FPG -16•2 mg/dL (intervention) and -0•7 mg/dL (control; p=0•001) Bodyweight -1•9 kg (intervention) and 0•5 kg (control; p=0•001); QoL 5•7 (intervention) and 2•3 (control; p&lt;0•001) Kim et al (2016), 86 China RCT; 6 months; 220; 83% Internet blood glucose monitoring system; participants uploaded BGL for monitoring by medical staff and received weekly recommendations regarding BGL control ΔHbA 1c -1•2% (intervention) and -0•6% (control; p&lt;0•001); postprandial BGL -0•9mmol/L (control) and -0•9mmol/L (intervention; p&lt;0•001) ΔHDL +0•1 mmol/L (control) and 0•0 mmol/L (intervention; p&lt;0•001); change in SBP, DBP, BMI, total cholesterol, LDL, and triglyderides not significant Leichter et al (2013), 87 China RCT; 3 months; 101; 84% Data management software with blood glucose meter; office visits at 6 and 12 months; visits via the internet and telephone at 3 and 9 months ΔHbA 1c at 12 months -0•55% (intervention) and -0•70% (control; p&gt;0•05) ΔBMI at 12 months: -0•60 kg/m² (intervention) and -0•32 kg/m² (control; p=0•09) McLeod et al (2020), 88 New Zealand RCT; 12 months; 429 with prediabetes or T2D; 96% Programme delivered through mobile devices and web-based platforms, which included individual health coaching, fortnightly provision of evidence-based resources, online peer support through a closed forum, and online goal tracking ΔHbA 1c in patients with T2D 0•0% (intervention) and 0•0% (control; p=0•366) ΔBMI: -0•4 kg/m² (intervention) and -0•2 kg/m² (control; p=0•464) (Table 1 continues on next page)</s></p><p xml:id="_uZg4f9P"><s xml:id="_HAJQDXm">included local food item options. <ref type="bibr" target="#b71">68</ref></s><s xml:id="_8vVaSze">Gamified technology was used to instil behaviour changes but this was not as successful. <ref type="bibr" target="#b68">65</ref></s><s xml:id="_n5qunhK">Website-based interventions comprised educational web pages, <ref type="bibr" target="#b87">84</ref> social network support groups, <ref type="bibr" target="#b61">58</ref> online counselling, <ref type="bibr" target="#b94">91</ref> and telemonitoring. <ref type="bibr" target="#b89">86</ref></s><s xml:id="_XWHcU8t">ost studies compared interventions to usual care or an enhanced version of usual care (eg, some form of education). <ref type="bibr" target="#b88">85</ref></s><s xml:id="_UxXb7jR">In most studies, education for the control group occurred only at baseline; <ref type="bibr" target="#b55">52</ref> however, there were a few studies that offered participants education throughout their duration.</s><s xml:id="_GmNRSWZ">A few studies offered very limited access to the digital health intervention for control participants, mostly at baseline. <ref type="bibr" target="#b58">55</ref></s><s xml:id="_wM8TNsP">verall, the methodological quality varied markedly with 26 (46%) studies classified as high risk of bias, six (11%) studies as moderate risk of bias, and 24 (43%) studies as low risk of bias (appendix p 51). 12 studies were assessed as high risk of bias for not masking participants and study personnel to intervention assignment or maintaining similar baseline characteristics; <ref type="bibr" target="#b41">[38]</ref><ref type="bibr" target="#b42">[39]</ref><ref type="bibr" target="#b43">[40]</ref><ref type="bibr" target="#b45">42,</ref><ref type="bibr" target="#b47">[44]</ref><ref type="bibr" target="#b48">[45]</ref><ref type="bibr" target="#b49">[46]</ref><ref type="bibr" target="#b50">[47]</ref><ref type="bibr" target="#b61">58,</ref><ref type="bibr" target="#b66">63,</ref><ref type="bibr" target="#b69">66,</ref><ref type="bibr" target="#b90">87</ref> however, such masking or even distribution of characteristics is typically not possible in digital interventions that target behaviour change. Eight studies did no</s><s xml:id="_ayssnNY"> provide complete information about the randomisation or the concealment process.</s><s xml:id="_q2Zd2dF"><ref type="bibr" target="#b42">39,</ref><ref type="bibr" target="#b49">46,</ref><ref type="bibr" target="#b62">59,</ref><ref type="bibr" target="#b65">62,</ref><ref type="bibr" target="#b79">76,</ref><ref type="bibr" target="#b85">82,</ref><ref type="bibr" target="#b92">89,</ref><ref type="bibr" target="#b93">90</ref> Regarding deviations from intended intervention, one study reported adjustments in study timeline were necessary due to Ramadan; <ref type="bibr" target="#b39">36</ref> and four studies did not report on the masking of participants.</s><s xml:id="_dSq6akX"><ref type="bibr" target="#b46">43,</ref><ref type="bibr" target="#b49">46,</ref><ref type="bibr" target="#b56">53,</ref><ref type="bibr" target="#b63">60</ref> Regarding attrition bias, 13 studies reported high attrition rates or inadequate method to eliminate potential bias caused by missing data, or both.</s><s xml:id="_eugsMJH"><ref type="bibr" target="#b45">42,</ref><ref type="bibr" target="#b46">43,</ref><ref type="bibr" target="#b49">46,</ref><ref type="bibr" target="#b53">50,</ref><ref type="bibr" target="#b54">51,</ref><ref type="bibr" target="#b58">55,</ref><ref type="bibr" target="#b60">57,</ref><ref type="bibr" target="#b69">66,</ref><ref type="bibr" target="#b70">67,</ref><ref type="bibr" target="#b82">79,</ref><ref type="bibr" target="#b83">80,</ref><ref type="bibr" target="#b87">84,</ref><ref type="bibr" target="#b90">87</ref> Regarding measurement bias, ten studies employed selfreporting of outcomes or did not provide information on adequate training of personnel for the measurement of outcomes.</s><s xml:id="_8REKgrX"><ref type="bibr" target="#b39">36,</ref><ref type="bibr" target="#b42">39,</ref><ref type="bibr" target="#b46">43,</ref><ref type="bibr" target="#b50">47,</ref><ref type="bibr" target="#b54">51,</ref><ref type="bibr" target="#b58">55,</ref><ref type="bibr" target="#b60">57,</ref><ref type="bibr" target="#b69">66,</ref><ref type="bibr" target="#b78">75,</ref><ref type="bibr" target="#b80">77</ref> Out of the 56 RCTs, trials that recruited participants with higher baseline values for HbA 1c reported the greatest effectiveness in terms of improving HbA 1c .</s><s xml:id="_tqV3Duv"><ref type="bibr" target="#b42">39,</ref><ref type="bibr" target="#b47">44,</ref><ref type="bibr" target="#b56">53,</ref><ref type="bibr" target="#b61">58,</ref><ref type="bibr" target="#b69">[66]</ref><ref type="bibr" target="#b70">[67]</ref><ref type="bibr" target="#b71">[68]</ref><ref type="bibr" target="#b88">85,</ref><ref type="bibr" target="#b90">87</ref> Pacaud and colleagues <ref type="bibr" target="#b92">89</ref> reported a significant reduction in HbA 1c in males only, but male participants had a higher baseline HbA 1c than females.</s><s xml:id="_2A5GzKe">A dose response was seen when participants used the application more than once per day.</s><s xml:id="_hjhXRjh"><ref type="bibr" target="#b64">61</ref> Education level was positively associated with Study design; duration; number of participants; retention Intervention Outcomes Primary Secondary (Continued from previous page) Pacaud et al (2012), 89 Canada RCT; 12 months; 79; 86% Intervention groups were Web Static intervention that received electronic education and virtual appointments using asynchronous communication (emails) and Web Interactive that received the same information via both synchronous and asynchronous communication ΔHbA 1c -0•37% (web interactive female), -1•58% (web interactive male), +0•07% (web static female), -0•44% (web static male), -0•65% (control female), and +0•06% (control male; significant differences for males but not for females) None Ralston et al (2009), 90 USA RCT; 12 months; 83; 89% Web-based programme for patient access to electronic medical records, secure email with providers, feedback on BGL, educational website, and interactive online diary logging information on physical activity, diet, and medication ΔHbA 1c -0•9% (intervention) and +0•2% (control; p&lt;0•01) BP, total cholesterol, and use of in-person healthcare services did not differ between the two groups Ramadas et al (2018), 91 Malaysia RCT; 12 months; 132; 86% e-intervention to deliver lessons based on the recommendations, objectives and dietary stages of change ΔHbA 1c -0•6% (intervention) and -0•5% (control; p=0•511) Dietary knowledge and attitude behaviour: F statistic=244•212 (intervention) and F statistic=62•453 (control; p&lt;0•001) Tang et al (2013), 92 USA RCT; 12 months; 415; 91% Wireless glucometer; diabetes summary status report regarding personalised action plan, goals, diabetes complications risk, monitoring tests, medications, and health maintenance schedule; diet and physical activity log; insulin record; online communication with health-care team; tailored text and video educational nuggets ΔHbA 1c at 6 months -1•32% (intervention) and -0•66% (control; p&lt;0•001); ΔHbA 1c at 12 months -1•14% (intervention) and -0•95% (control; p=0•132); LDL at 12 months 0•0 mg/dL (control) and -6•1 mg/dL (intervention; p=0•001) Framingham risk -0•5% (control) and -0•6% (intervention; p=0•051); SBP, DBP, and bodyweight did not differ significantly between groups Zhou et al (2014), 93 China Prospective RCT; 3 months; 114; 95% Web-based system as main intervention but professional staff also contacted participants via SMS, online communication, and telephone ΔHbA 1c -95% (intervention) and -0•79% (control; p&lt;0•001) ΔFBG 1•89 mmol/L (intervention) and -0•95 mmol/L (control; p&lt;0•005); no significant change in BMI and BP between groups 2 h PG=2 hour postprandial plasma glucose.</s><s xml:id="_8WjqXAn">app=application. BGL=blood glucose level</s><s xml:id="_vruczUM">BP=blood pressure. CVD=cardiovasc</s><s xml:id="_UeNbZVT">ar disease. DBP=diastolic blood pressure. FPG=fast</s><s xml:id="_NKVSAJD">FPG=fasting plasma glucose. HbA 1c =glycated haemoglobin </s><s xml:id="_A2QruqE">1c .</s><s xml:id="_uwPbrKH">HTN=hypertension. LDL=low-density lipopro</s><s xml:id="_HPBNq8x">in. Qo</s><s xml:id="_nZ7D9sx">=quality of life.</s><s xml:id="_fM9fHUh">RCT=randomised control trial.</s><s xml:id="_WaUJHHE">SBP=systolic blood pressure. SM</s><s xml:id="_Jqzv3Dz">G=self-monitoring of blood glucose.</s><s xml:id="_m8TBEZ3">T2D=type 2 diabetes.</s><s xml:id="_Nnrxa32">*Reported values are approximations of combined reported values for different subgroups within the study. A </s><s xml:id="_QDfwJyD">ull version of the study characteristics including details on participant baseline characteristics, the control group, and the purpose of the study can be found in the appendix (pp 19-47).</s></p><p xml:id="_uYW4Rva"><s xml:id="_K2dVU8C">Table 1: Characteristics of included studies that incorporated SMS, smartphone application, and website-based interventions</s></p><p xml:id="_2aMqbQF"><s xml:id="_5eYvG8h">intervention effectiveness. <ref type="bibr" target="#b65">62,</ref><ref type="bibr" target="#b66">63,</ref><ref type="bibr" target="#b71">68,</ref><ref type="bibr" target="#b77">74,</ref><ref type="bibr" target="#b83">80</ref></s><s xml:id="_6kQ4uKD">34 studies reported clinically meaningful reductions in HbA 1c (≥0•5%) for their digital health intervention group, <ref type="bibr" target="#b41">38,</ref><ref type="bibr" target="#b43">40,</ref><ref type="bibr" target="#b45">[42]</ref><ref type="bibr" target="#b46">[43]</ref><ref type="bibr" target="#b47">[44]</ref><ref type="bibr" target="#b48">[45]</ref><ref type="bibr" target="#b51">48,</ref><ref type="bibr" target="#b54">[51]</ref><ref type="bibr" target="#b55">[52]</ref><ref type="bibr" target="#b56">[53]</ref><ref type="bibr" target="#b57">[54]</ref><ref type="bibr" target="#b58">[55]</ref><ref type="bibr" target="#b59">[56]</ref><ref type="bibr" target="#b60">[57]</ref><ref type="bibr" target="#b62">59,</ref><ref type="bibr" target="#b63">60,</ref><ref type="bibr" target="#b67">64,</ref><ref type="bibr" target="#b68">65,</ref><ref type="bibr" target="#b70">67,</ref><ref type="bibr" target="#b71">68,</ref><ref type="bibr" target="#b74">71,</ref><ref type="bibr" target="#b75">72,</ref><ref type="bibr" target="#b77">74,</ref><ref type="bibr" target="#b78">75,</ref><ref type="bibr" target="#b80">[77]</ref><ref type="bibr" target="#b81">[78]</ref><ref type="bibr" target="#b82">[79]</ref><ref type="bibr" target="#b83">[80]</ref><ref type="bibr" target="#b85">82,</ref><ref type="bibr" target="#b87">84,</ref><ref type="bibr" target="#b93">[90]</ref><ref type="bibr" target="#b94">[91]</ref><ref type="bibr" target="#b95">[92]</ref><ref type="bibr" target="#b96">[93]</ref> compared with 24 that reported clinically meaningful reductions for their control group. <ref type="bibr" target="#b41">38,</ref><ref type="bibr" target="#b47">44,</ref><ref type="bibr" target="#b54">51,</ref><ref type="bibr" target="#b55">52,</ref><ref type="bibr" target="#b57">54,</ref><ref type="bibr" target="#b60">57,</ref><ref type="bibr" target="#b62">59,</ref><ref type="bibr" target="#b63">60,</ref><ref type="bibr" target="#b67">64,</ref><ref type="bibr" target="#b70">67,</ref><ref type="bibr" target="#b71">68,</ref><ref type="bibr" target="#b74">71,</ref><ref type="bibr" target="#b75">72,</ref><ref type="bibr" target="#b77">74,</ref><ref type="bibr" target="#b78">75,</ref><ref type="bibr" target="#b80">77,</ref><ref type="bibr" target="#b81">78,</ref><ref type="bibr" target="#b83">80,</ref><ref type="bibr" target="#b85">82,</ref><ref type="bibr" target="#b87">84,</ref></s><s xml:id="_e6za2Yv"><ref type="bibr" target="#b94">[91]</ref><ref type="bibr" target="#b95">[92]</ref><ref type="bibr" target="#b96">[93]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aDKWGnA">Intervention</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VkaC9CZ">Mean SD Total</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TetVGNN">Control</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ttMjbE9">Mean SD Total</head><p xml:id="_vdrmnz9"><s xml:id="_GPy9MFk">Weight Mean difference inverse variance, random (95% CI)</s></p><formula xml:id="formula_0">-0•06 -1•05 -0•90 -0•41 -0•86 -0•20 -0•06 -1•77 -0•70 -0•70 -3•02 0•26 -0•33 -1•50 -1•90 -0•20 -0•55 -2•00 -1•70 -1•07 -0•4 -1•10 -1•95 1•20 0•00 -0•90 -0•54 0•84 0•52 1•80 1•21 1•08 0•21 0•96 1•73 0•33 0•84</formula><p xml:id="_Rkn2NNS"><s xml:id="_YBNHYVe">2•83 0•35 0•26 1•10 1•60 0•21 2•47 1•80 2•00 0•89 0•80 0•30 1•70 1•50 0•79 1•10 1•33 65 64 177 58 106 537 159 26 33 1225 84 102 32 79 44 17 150 44 37 25 44 7 48 50 763 92 108 39 63 30 2290 -0•40 -0•60 -0•10 0•09 -0•18 0•03 -0•06 -0•96 -0•03 -0•10 -1•30 -0•19 -0•28 -0•80 -1•00 0•1 0 -0•70 -1•11 -0•30 -0•62 0•10 -1•10 -0•79 0•60 0•00 0•20 -0•57 1•11 0•59 1•80 1•24 1•53 0•22 0•96 1•70 0•43 0•58 3•29 0•14 0•26 1•60 1•00 0•21 2•94 2•20 1•40 1•00 0•70 0•40 1•10 0•80 0•54 1•10 1•33 66 64 116 51 94 586 159 21 32 1189 80 100 39 83 47 18 150 41 29 27 47 15 47 50 773 90 114 35 55 294 2256  Forest plot of mean difference in HbA 1c (expressed as percentage) between the digital health intervention and the usual care group, and subgroup analysis by mode of delivery of the intervention (ie, SMS, smartphone application, and website).</s><s xml:id="_5WKwwzK">The size of the squares indicates the weight of the evidence from each of the studies; studies with CI (horizontal line) crossing zero (vertical line) are inconclusive; powerful studies (those with more participants) have narrower CIs; the diamonds represent the summary effect sizes in each of the subgroups and in the overall sample, with the width of the diamond indicating the 95% CI.</s><s xml:id="_V7rUHqr">A statistically greater significant reduction in HbA 1c is seen in the digital health intervention group, compared with the control group in the overall sample and with the SMS and smartphone application modes of delivery but not when websites were used as the mode of delivery of the intervention.</s><s xml:id="_xBjvVfh">The data present substantial heterogeneity.</s><s xml:id="_eNZWafe">HbA 1c =glycated haemoglobin A 1c .</s></p><formula xml:id="formula_1">4•1% 5•5% 3•4% 3•1% 3•8% 6•5% 5•3% 1•1% 5•5% 38•4% 5•2% 1•4% 6•0% 6•3% 2•5% 1•3% 6•5% 0•8% 1•1% 1•2% 3•7% 1•9% 5•9% 2•5% 46•2% 4•0% 5•6% 2•8% 3•0%<label>15</label></formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3nwcxZr">Mode of delivery</head><p xml:id="_gFTRMNj"><s xml:id="_VMUbc55">Percentage reach (randomly assigned proportion) Uptake Feasibility Abaza and Marschollek (2017) 36 SMS 12•7% (50•0%) NR Feasible based on high levels of satisfaction, acceptance, and improvement of clinical outcome (effectiveness) Anzaldo-Campos et al (2016) 57 Smartphone app 12•1% (66•8%) 75•0% Feasible showing improvement of clinical outcomes (ie, declines in HbA 1c levels [effectiveness]) Argay et al (2015) 37 SMS NR (50•0%) NR NR Arora et al (2014) 38 SMS 15•4% (50•0%) NR NR; participant reported high satisfaction and would recommend TExT-MED to a family member or friend with diabetes; intervention was accessible, effective, and of low cost Bender et al (2017) 58 Smartphone app 11•8% (48•9%) 100•0% Feasible based on achieving recruitment target (100%), high engagement (95•0% in intervention; 100•0% in control), retention threshold goals (100•0%), and adherence Capozza et al (2015) 39 SMS NR (66•0%) 81•6% Feasible based on high satisfaction among patients Chao et al (2019) 59 Smartphone app 3•8% (51•2%) NR NR Dobson et al (2020) 40 SMS 23•1% (50•0%) NR NR; reported on high acceptance and effectiveness Dong et al (2018) 60 Smartphone app NR (50•0%) NR NR Fang et al (2018) 41 SMS 52•2% (51•9%) NR NR Fortmann et al (2017) 42 SMS 7•6% (50•0%) NR Feasible based on high acceptance, that participant would recommend Dulce Digital to a friend or family member with diabetes; intervention was clinically effective and cost-effective Franc et al (2020) 61 Smartphone app NR (66•8%) 31•1% NR Frias et al (2017) 62 Smartphone app 46•3% (69•5%) 86•0% NR; reported only high satisfaction and adherence.</s><s xml:id="_WwHeTuA">Gong et al (2020) 63 Smartphone app 19•9% (49•7%) 98•9% NR; reported that participants had good adoption of the programme and completed a substantial amount of chats with the intervention over 12 months Goodarzi et al (2012) 43 SMS NR (50•0%) NR NR Gunawardena et al (2019) 64 Smartphone app 22•3% (52•2%) &gt;80•0% Feasible based on usefulness and effectiveness Hansel et al (2017) 83 Website 43•8% (50%) 93•0% Feasible based on high satisfaction (or appreciation) and ease of use among participants; 77% would recommend using the programme for patients like them Heisler et al (2019) 84 Website 18•3% (50•3%) NR NR Hilmarsdóttir et al (2021) 65 Smartphone app 39•1% (48•6%) 88•9% NR; feasible as an add-on support for patients who are motivated to use technical solutions Shariful Islam et al (2015) 48 SMS NR (50•0%) NR NR Jaipakdee et al (2015) 85 Website 78•3% 93•6% NR; reported that 90•3% of the participants who had received the intervention were satisfied or very satisfied with it, and 59•0% intended to continue the programme, and 64•1% intended to recommend the programme to others; 80% of the primary health-care centres adopted the intervention Kim et al (2016) 86 Website NR (50•0%) NR NR; reported only cost-effectiveness Kim et al (2010) 44 SMS NR (50•0%) NR NR; reported high adherence or uptake, usability, and effectiveness Kleinman et al (2016) 66 and Kleinman et al (2017) 67 Smartphone app 41•5% (48•4%) 88•6% NR; reported only satisfaction Ku et al (2020) 68 Smartphone app 43•5% (50•0%) NR NR; reported only the effectiveness Kumar et al (2021) 69 Smartphone app 25•9% (50•0%) NR NR Lee et al (2020) 70 Smartphone app 56•2% (56•9%) 54•0% NR; reported only higher satisfaction Leichter et al (2013) 87 Website NR (50•0%) 75•5% Feasible based on practicality and acceptability (low dropout) Li et al (2021) 71 Smartphone app 46•2% (54•5%) NR Feasible based on adherence and effectiveness Lim et al (2011) 45 SMS 28•3% (33•1%) NR NR; reported patient satisfaction and other conveniences associated with the implementation Lu et al (2021) 72 Smartphone app 50•0% NR NR; reported only the effectiveness McLeod et al (2020) 88 Website 38•1% (50•1%) 91•6% NR; reported only high cost associated with the programme and adherence (Table 2 continues on next page)</s></p><p xml:id="_SrR39mU"><s xml:id="_Kz488xB">26 studies (4546 participants) were included in the metaanalysis on Hba 1c . <ref type="bibr" target="#b40">37,</ref><ref type="bibr" target="#b41">38,</ref><ref type="bibr" target="#b43">40,</ref><ref type="bibr" target="#b44">41,</ref><ref type="bibr" target="#b49">[46]</ref><ref type="bibr" target="#b50">[47]</ref><ref type="bibr" target="#b51">[48]</ref><ref type="bibr" target="#b57">[54]</ref><ref type="bibr" target="#b58">[55]</ref><ref type="bibr" target="#b59">[56]</ref><ref type="bibr" target="#b60">[57]</ref><ref type="bibr" target="#b65">62,</ref><ref type="bibr" target="#b66">63,</ref><ref type="bibr" target="#b69">[66]</ref><ref type="bibr" target="#b70">[67]</ref><ref type="bibr" target="#b71">[68]</ref><ref type="bibr" target="#b72">[69]</ref><ref type="bibr" target="#b74">71,</ref></s><s xml:id="_MxpGTwz">1,<ref type="bibr" target="#b77">[74]</ref><ref type="bibr" target="#b78">[75]</ref><ref type="bibr" target="#b79">[76]</ref><ref type="bibr" target="#b81">78,</ref><ref type="bibr" target="#b85">82,</ref><ref type="bibr" target="#b89">86,</ref><ref type="bibr" target="#b91">88,</ref><ref type="bibr" target="#b93">90,</ref><ref type="bibr" target="#b94">91</ref> Data on secondary outcomes were not sufficient because they were not reported in enough of the primary research papers to warrant a meta-analysis.</s><s xml:id="_cFGYA5N">Of the included studies in the meta-analysis, five SMS interventions were assessed as high risk of bias, <ref type="bibr" target="#b41">38,</ref><ref type="bibr" target="#b43">40,</ref><ref type="bibr" target="#b50">47,</ref><ref type="bibr" target="#b51">48,</ref><ref type="bibr" target="#b58">55</ref> and four as low. <ref type="bibr" target="#b40">37,</ref><ref type="bibr" target="#b44">41,</ref><ref type="bibr" target="#b49">46,</ref><ref type="bibr" target="#b57">54</ref></s><s xml:id="_QaNK8HC">The four website-based interventions were assessed as low risk of bias. <ref type="bibr" target="#b89">86,</ref><ref type="bibr" target="#b91">88,</ref><ref type="bibr" target="#b93">90,</ref><ref type="bibr" target="#b94">91</ref></s><s xml:id="_2MThMhp">Regarding smartphone application interventions, six scored as low risk of bias, <ref type="bibr" target="#b59">56,</ref><ref type="bibr" target="#b70">67,</ref><ref type="bibr" target="#b71">68,</ref><ref type="bibr" target="#b79">76,</ref><ref type="bibr" target="#b81">78,</ref><ref type="bibr" target="#b85">82</ref> five as high, <ref type="bibr" target="#b60">57,</ref><ref type="bibr" target="#b65">62,</ref><ref type="bibr" target="#b69">66,</ref><ref type="bibr" target="#b77">74,</ref><ref type="bibr" target="#b78">75</ref> and two scored as having some concerns. <ref type="bibr" target="#b66">63,</ref><ref type="bibr" target="#b72">69</ref></s><s xml:id="_tha7c8x">Overall, participants receiving a digital health intervention achieved a -0•30 (95% CI -0•42 to -0•19) percentage point greater reduction in HbA 1c , compared with those receiving usual care (figure <ref type="figure" target="#fig_2">2</ref>).</s><s xml:id="_mqQWdNN">Smartphone application interventions produced the greatest HbA 1c reduction compared with usual care (-0•42% [95% CI -0•63 to -0•20]), followed by SMS (-0•37% [-0•57 to -0•17]).</s></p><p xml:id="_vYPWGHp"><s xml:id="_wcZeyS5">Mode of delivery Percentage reach (randomly assigned proportion) Uptake Feasibility (Continued from previous page) Omar et al (2020) 56 Smartphone app 27•3% (50•0%) NR NR; reported high satisfaction with intervention; regarded as beneficial (80•0%) and convenient (67•0%), and agreed to continue to use it if it were to continue in the future (90%) Or et al (2020) 73 Smartphone app 33•3% (50•5%) NR NR Pacaud et al (2012) 89 Website NR (69•1%) NR NR; reported only the satisfaction Peimani et al (2016) 49 SMS 25% (66•7%) NR NR Quinn et al (2016) 74 Smartphone app NR (65•6%) NR NR; reported only satisfaction with the programme and engagement Ralston et al (2009) 90 Website 5•9% (50•6%) 76•0% NR Ramadas et al (2018) 91 Website 34•6% (50•0%) NR NR Ramallo-Fariña et al (2020) 46 SMS 27•3% (74•9%) NR NR; reported on the necessity of patient empowerment and digital literacy to make the intervention successful Sadanshiv et al (2020) 47 SMS 37•4% (50•3%) 80•1% Feasible based on high satisfaction, high percentage of users who received content (48•1%), received regularly (95•7%), read (93•2%), and acted (80•1%) on the SMS at 6 months Shetty et al (2011) 50 SMS NR (51•2%) NR Feasible based on high acceptance, cost-effectiveness and practicability Sun et al (2019) 75 Smartphone app NR NR NR; reported high overall satisfaction Tamban et al (2014) 51 SMS 41•6% (50•0%) NR NR Tang et al (2013) 92 Website 12•7% (48•7%) 88•0% NR; reported low treatment distress, greater overall treatment satisfaction (27•7%) and willingness to recommend treatment to others Vinitha et al (2019) 52 SMS 48•3% (50•8%) NR NR; reported only acceptability Waki K et al (2014) 76 Smartphone app 40•9% (50•0%) 88•9% NR; reported only effectiveness and convenience for patients Wang et al (2019) 77 Smartphone app NR (50•0%) NR (control: 100•0%) NR; reported only effectiveness and reduction of hospitalisation cost Wargny et al (2018) 53 SMS 93•2% (both groups received intervention at different timepoints) 97•0% NR; reported only convenience and suitability for a low-income setting Whittemore et al (2020) 54 SMS 21•1% (50•5%) NR Feasible based on high rates of recruitment, implementation fidelity, attendance, and attrition Xu et al (2020) 55 SMS 9•5% (50•8%) 63•6% NR; reported on low cost, accessible, and facilitates high engagement for patients of different ages, health literacy, and socioeconomic levels Yu et al (2019) 78 Smartphone app 46•5% (50•3%) NR NR Yun et al (2020) 79 Smartphone app 42•1% (50•0%) NR (control: 77•4%) NR; reported only sustainability and cost-effectiveness Zhang et al (2019) 80 and Zhang et al (2019) 81 Smartphone app 56•5% (66•7%) NR (frequencies of app usage in groups B and C were 10•7 [SD 9•5] times per week) NR; reported only effectiveness Zhou et al (2016) 82 Smartphone app NR (50•0%) 100•0% Feasible based on effectiveness and high satisfaction rate Zhou et al (2014) 93 Website NR (50•0%) NR NR NR=not reported.</s><s xml:id="_k8Fy9Gu">app=application.</s></p><p xml:id="_ZZ6Zf3h"><s xml:id="_e36n5wQ">Table 2: Reach, uptake, and feasibility of included interventions Website-based interventions did not achieve a statistically significant HbA 1c reduction com pared with usual care (-0•09% [-0•64 to 0•46]).</s></p><p xml:id="_bsBdrYU"><s xml:id="_QGqy7HU">The heterogeneity between the studies was statistically significant (Q=289•56, p&lt;0•0001) and considerable in magnitude (I²=91%).</s><s xml:id="_YFS2sSD">The sensitivity analyses to assess the robustness of the effect estimate are described in the appendix (p 52).</s><s xml:id="_GF7prYK">Publication bias was assessed via visual inspection of a funnel plot (appendix p 53).</s><s xml:id="_rQ8aTE4">The data displayed a slightly skewed distribution.</s><s xml:id="_5TTQTUc">The asymmetry observed is due to an excess of smartphone application medium-sample-size interventions with positive effects on the outcome (HbA 1c reduction), but it does not indicate a serious publication bias.</s></p><p xml:id="_ZdQwAXR"><s xml:id="_SwZZjDk">Overall, the evidence was considered inconsistent due to the considerable heterogeneity of the study design (figure <ref type="figure" target="#fig_2">2</ref>) and thus the level of evidence was downgraded (appendix p 9).</s><s xml:id="_BnWhmKY">Therefore, the overall score for the level of evidence was moderate.</s></p><p xml:id="_Q7Jfq3P"><s xml:id="_DtDWcre">43 studies reported an intervention reach based on the assessed population for inclusion into the studies (ie, the authors reported how many people in total they reached when recruiting for the intervention), with a median reach of 33•6% (range 3•8-93•2), whereas 15 studies reported only the randomly assigned populations, with a median of 50•6% (50•0-69•1) randomly assigned to the intervention groups (one study did not report reach).</s><s xml:id="_NQpEu5Y">21 studies reported intervention uptake, with a median uptake of 87</s></p><p xml:id="_penn4hE"><s xml:id="_VvrmBND">•5% (31•1-100•0%).</s><s xml:id="_bsXf7Tw">Smartphone application interventions reported higher reach compared with SMS and website-based interventions, but website-based interventions reported higher uptake compared with the other two intervention types (table 2).</s></p><p xml:id="_AJRsyng"><s xml:id="_qTb5KAK">The authors of 13 studies concluded that the interventions were feasible based on measures of meeting recruitment target, high response rate, retention, adherence, acceptance and compliance rates, efficacy, sustainability, fidelity, cost-effectiveness, usefulness, and high accessibility.</s><s xml:id="_W3Dpjyg">Authors of 27 studies did not explicitly conclude that the interventions were feasible, but they did report high adherence, satisfaction, usability, convenience and engagement, high likelihood of recommending the intervention to others, high acceptance, and cost-effectiveness (table <ref type="table">2</ref>).</s><s xml:id="_kKNXkmg">We reported authors' interpretations of study feasibility as the components of feasibility measurement varied between studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dcEgyfY">Discussion</head><p xml:id="_BymH7Y7"><s xml:id="_6DwnVfy">This systematic review synthesised the evidence of 56 studies on the effectiveness, reach, uptake, and feasibility of smartphone applications, SMS, and websitebased interventions in 11 486 adults with type 2 diabetes.</s><s xml:id="_qPu7w32">The meta-analysis of 26 studies (n=4546 participants) compared the three different modes of delivery and identified that smartphone application and SMS interventions were more effective in terms of glycaemic control than website interventions.</s><s xml:id="_zh7dzQ3">Additionally, smartphone application interventions displayed the greatest reach, although website-based interventions had greater uptake.</s></p><p xml:id="_PWf9pVh"><s xml:id="_vKWv5YM">Several reasons could explain the superior effectiveness that smartphone application and SMS interventions exhibited over interventions that were delivered via websites.</s><s xml:id="_JKM9RzS">First, due to technological advancements, modern smartphones include an array of capabilities, such as communication with wearable or ingestible sensors, <ref type="bibr" target="#b65">62,</ref><ref type="bibr" target="#b66">63</ref> that permit continuous monitoring and can there fore improve results.</s><s xml:id="_8PDjRNd">Second, the synchronous communication abilities, such as video conferencing, allow health-care practitioners to intervene more rapidly than via asynchronous means. <ref type="bibr" target="#b15">12</ref></s><s xml:id="_xgbHj7k">Third, SMS and smartphone applications might be more user-friendly and easier to access due to the convenient and portable nature of mobile phones, as compared to websites that might require access to a laptop or desktop to engage with the services.</s><s xml:id="_eGgjqXV">In fact, studies have previously demonstrated that even between smartphones (eg, iPhones and Androids) usability factors determine the time required to complete health-related tasks. <ref type="bibr" target="#b98">95</ref></s><s xml:id="_7ZAufap">However, other reports indicate that fixed devices are preferred over mobile ones, especially when the objective is to complete large tasks. <ref type="bibr" target="#b99">96</ref></s><s xml:id="_qRb3qhS">ur meta-analysis found SMS and smartphone application interventions to be effective compared to usual care, in agreement with previous reports. <ref type="bibr" target="#b100">[97]</ref><ref type="bibr" target="#b101">[98]</ref></s><s xml:id="_DZygZGN">8]<ref type="bibr" target="#b102">[99]</ref> This finding means that either of these two modes of digital health intervention delivery can be used effectively and the decision regarding how to deliver the intervention should be based on the context of the intervention, the sociodemographic characteristics of the participants, and the behaviour that the intervention intends to target.</s></p><p xml:id="_5Njuw2n"><s xml:id="_cgAnR6W">Participants' education level and higher baseline hyperglycaemia were both associated with larger reductions in glycaemia.</s><s xml:id="_4xmVYjF">This association is plausible, because of homoeostatic regulatory mechanisms, whereby the further a physiological value deviates from the typical range, the greater the homoeostatic pressure is to correct this deviation following intervention.</s><s xml:id="_sMheDhF">This hypothesis also explains why in the study by Pacaud and colleagues, 89 a significant reduction in HbA 1c was only seen in male participants, because males included in this study had a higher baseline HbA 1c than the included females. <ref type="bibr" target="#b92">89</ref></s><s xml:id="_ahvB23E">Future studies should incorporate effect modification analyses based on the baseline HbA 1c value.</s><s xml:id="_s8zGvEz">Regarding participants' education being a moderator of effectiveness, digital health tools were predominantly used for education, telemonitoring, and communication between participants and health-care professionals; therefore it makes sense that participants with a higher education status experienced the greatest benefit.</s><s xml:id="_yGAMM4S">However, it is known that the prevalence of type 2 diabetes is higher in populations of a lower socioeconomic and education status, 100 and future interventions should aim to optimise effectiveness in these populations.</s><s xml:id="_p7ZdKa9">Several interventions translated their protocols to the mother tongue of participants to tailor the contents of SMS messages to the educational status and cultural background of their participants; however, this approach was not always successful, suggesting other reasons as being more important for the success of such inter ventions. <ref type="bibr" target="#b41">[38]</ref><ref type="bibr" target="#b42">[39]</ref></s><s xml:id="_aBZGrte">]<ref type="bibr" target="#b43">[40]</ref> Most study authors reported reach and adoption or uptake at the participant's level.</s><s xml:id="_Vt3MywP">Future studies should also report reach and adoption of the intervention at the implementer's level and at the broader community or cohort's level.</s><s xml:id="_ExkvQ6K">We found comparing feasibility between the studies challenging, due to the inconsistency of implementation and evaluation metrics reporting.</s><s xml:id="_gm99bhu">A comprehensive framework that combines several implementation guidelines and provides direction for how to operationalise evaluation and implementation frame work components is needed.</s><s xml:id="_aEbWzJK">The absence of existing guidelines and frameworks' systematisation and agreement on construct naming and definitions did not permit a robust implementation evidence synthesis.</s></p><p xml:id="_yfzaPSU"><s xml:id="_36RYum3">The included studies exhibited substantial heterogeneity.</s><s xml:id="_ydFqH3T">In addition to employing a different mode of digital health intervention delivery, studies used these tools in different ways.</s><s xml:id="_6kP8vNB">The simplest study designs included reminders to take medication.</s><s xml:id="_kN3N7Ah">Education of participants was employed nearly universally.</s><s xml:id="_PskXur2">More complex study designs involved sophisticated real-time monitoring of biomarkers.</s><s xml:id="_UtUYJ98">Finally, some studies incorporated motivation and the delivery of compre hensive behavioural change interventions.</s><s xml:id="_WpzHRur">Therefore, the superior effectiveness of smartphone applications could also be explained in terms of their capabilities to deliver all these approaches, compared with the other two tools that can only deliver some of them.</s><s xml:id="_cwpBNsK">Future programmes should leverage these increased capabilities to deliver holistic interventions.</s></p><p xml:id="_uXzYdyc"><s xml:id="_6tZtrcm">Strengths of this review include the use of rigorous standard methodology as documented in the PRISMA and Cochrane guidelines for conducting systematic reviews and meta-analyses; a very large, demographically and culturally diverse population from 24 regions representing lower-middle-income, upper-middleincome, and high-income economy countries from six continents; the direct communication with study authors to derive accurate data for the analyses; the comprehensive series of sensitivity analyses performed to ensure the robustness of the calculated summary effect size; and the inclusion of implementation metrics.</s></p><p xml:id="_frjjYck"><s xml:id="_hEXvqre">This study also has limitations.</s><s xml:id="_n6xdTCP">First, searches were restricted to articles published in English.</s><s xml:id="_rErj69u">However, reports indicate that the difference is only one out of every 36 meta-analyses when the non-English publications are included. <ref type="bibr">101</ref></s><s xml:id="_zHDHAFc">Second, we searched five scientific databases for studies in adults.</s><s xml:id="_GCKy8Se">The adult filter is not consistent between these databases.</s><s xml:id="_sbJHrSr">In MEDLINE, the adult filter is 19 years of age or older, whereas for Embase and PsycInfo it is 18 years of age or older.</s><s xml:id="_wZkr8su">This difference means that articles listed in MEDLINE with participants aged 18-19 years might have been missed, but the proportion of the population with type 2 diabetes at that age is small. 102</s><s xml:id="_U4yqyWV">Third, most SMS interventions reported on frequency, but very few smartphone application interventions reported on the frequency of use of the application and time spent using it.</s><s xml:id="_s5FnUeH">Not having this data limits the analysis and conclusions on a dose-response relationship, because the frequency of application use appeared to moderate the effectiveness in one intervention, <ref type="bibr" target="#b64">61</ref> in which only the participants that used the application more than once a week achieved a significant reduction in their HbA 1c .</s><s xml:id="_CXDpPWb">Future studies should examine this relationship further and ensure clear reporting of the frequency and time spent on engaging with the intervention.</s><s xml:id="_sPYH4hV">Fourth, some studies included more than one digital mode of delivery of the intervention.</s><s xml:id="_FTnnQpa">For example, Capozza and colleagues <ref type="bibr" target="#b42">39</ref> reported conducting an SMS intervention but also employed a webportal where patients could view their data, and make associations between their behaviours and test results.</s><s xml:id="_pwwkd8J">This mode overlap poses a limitation when a comparison between modes is the objective.</s><s xml:id="_TeQDvwj">We respected the authors' report in terms of mode of delivery when deciding how to classify these studies, but we acknowledge the inherent limitation of this.</s><s xml:id="_5WQmQ3F">Fifth, most studies reported on clinical parameters, such as HbA 1c and homoeostatic model assessment of insulin resistance, but very few studies reported on long-term clinical outcomes such as incidence of cardio vascular disease, amputations, and mortality.</s><s xml:id="_WP6PhyR">The duration of RCTs does not permit the examination of most of these outcomes, for which longitudinal studies are better suited.</s><s xml:id="_ZjEU98F">However, future studies should also explore how the different modes of digital health interventions compare in terms of the reduction of the risk of complications in people with diabetes.</s><s xml:id="_7WSED9Y">Sixth, studies in the mobile application group were on average more recent (2020) than those in the SMS (2017) and website (2016) groups, which might limit some of the conclusions-eg, regarding the uptake of the interventions.</s><s xml:id="_Awrhv9h">Seventh, there was great heterogeneity in terms of studies' objectives, ranging from simple participant education to tailored insulin dose titration, presenting another limitation for comparisons when the study design might have been optimised to the different objectives.</s><s xml:id="_G4b85YH">Eighth, few studies assessed differences in outcomes between genders.</s><s xml:id="_pJEW7sx">Future studies should employ gender-based analysis to facilitate such understanding.</s><s xml:id="_WyZejfP">Ninth, the evaluation of reach, adoption, and uptake is not able to be fully comprehensive in the context of the studies included in this review, as it is limited by the fact that these were not primary aims of the included studies.</s><s xml:id="_vqjn27X">A future assessment in the context of a focused systematic review of these measures can help to evaluate the potential for translation to practice.</s></p><p xml:id="_zVtkYwV"><s xml:id="_FAGAcVW">In summary, SMS and smartphone application interventions, but not website-based interventions, were associated with improved glycaemic control, compared with usual care, across diverse samples.</s><s xml:id="_HVFSwWu">At the same time, we recognise that there was considerable heterogeneity of studies.</s><s xml:id="_DHjyAmf">Considering that both smartphone application and SMS interventions are effective for diabetes management, clinicians should consider factors such as reach, uptake, patient preference, and context of the intervention when deciding on the mode of delivery of the intervention.</s><s xml:id="_rU3EUsT">Nine-in-ten people worldwide own a feature phone or a smartphone and can receive SMS, and six-in-seven people have access to a smartphone, with numerous smartphone applications being currently available for diabetes management.</s><s xml:id="_PnUJaYB">Clinicians should familiarise themselves with this modality of programme delivery and encourage people with type 2 diabetes to use evidence-based SMS and smartphone application interventions for improving their self-management of diabetes.</s><s xml:id="_qdMchpF">Given the probable effectiveness of digital health interventions and their growing trend, clinicians can potentially leverage the high penetration rates and reach in diverse populations to deliver interventions. <ref type="bibr">[103]</ref><ref type="bibr">[104]</ref></s><s xml:id="_jvX7DJk">4]<ref type="bibr">[105]</ref><ref type="bibr">[106]</ref><ref type="bibr">[107]</ref><ref type="bibr">[108]</ref> This approach is of particular importance for rural and remote populations with limited health services and where diabetes prevalence is higher.</s><s xml:id="_8WZXMhU">Future research needs to describe in detail the mediators and moderators of the effectiveness and implementation of these interventions, such as the optimal dose, frequency, timing, user interface, and communication mode to both further improve their effectiveness and to increase reach, uptake, and feasibility of treatments, as a number of included studies did not report on these.</s><s xml:id="_6mefz7k">Finally, as our review included studies conducted in high-income, upper-middle-income, and lower-middle-income-economies, future studies should also examine the effectiveness of these interventions in low-income economies.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc><div><p xml:id="_wwR83du"><s xml:id="_veBPUSJ">68 (-1•05 to -0•31) -0•23 (-0•26 to -0•20) 0•00 (-0•21 to 0•21) -0•81 (-1•80 to 0•18) -0•67 (-0•86 to -0•48)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 :</head><label>2</label><figDesc><div><p xml:id="_pvt6A5S"><s xml:id="_f3SFTtW">Figure 2: HbA 1c meta-analysisForest plot of mean difference in HbA 1c (expressed as percentage) between the digital health intervention and the usual care group, and subgroup analysis by mode of delivery of the intervention (ie, SMS, smartphone application, and website).</s><s xml:id="_UDwUcCW">The size of the squares indicates the weight of the evidence from each of the studies; studies with CI (horizontal line) crossing zero (vertical line) are inconclusive; powerful studies (those with more participants) have narrower CIs; the diamonds represent the summary effect sizes in each of the subgroups and in the overall sample, with the width of the diamond indicating the 95% CI.</s><s xml:id="_ZScKz3E">A statistically greater significant reduction in HbA 1c is seen in the digital health intervention group, compared with the control group in the overall sample and with the SMS and smartphone application modes of delivery but not when websites were used as the mode of delivery of the intervention.</s><s xml:id="_wFjvAQw">The data present substantial heterogeneity.</s><s xml:id="_TstPM6Y">HbA 1c =glycated haemoglobin A 1c .</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_fFCEj4z"><s xml:id="_E7phqH4">www.thelancet.com/digital-health</s><s xml:id="_nrb5t9G">Vol 5 March 2023</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_TTuR4VB"><s xml:id="_jZg3sH4">www.thelancet.com/digital-health</s><s xml:id="_f2q95nC">Vol 5 March 2023 e137</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_JVstmnb"><s xml:id="_QQzHXQH">www.thelancet.com/digital-health</s><s xml:id="_4EVnymu">Vol 5 March 2023 e139</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_h5mUT4q"><s xml:id="_jWvPXHC">www.thelancet.com/digital-health</s><s xml:id="_jBYpBbX">Vol 5 March 2023 e143</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_RJSqNj7">Acknowledgments</head><p xml:id="_WmNkrkQ"><s xml:id="_YHaAMP9">The <rs type="projectName">DigiCare4You study</rs> has received funding from the <rs type="funder">EU</rs>'s <rs type="programName">Horizon 2020 Research and Innovation Programme</rs> (grant agreement <rs type="grantNumber">945246</rs>).</s></p></div>
			</div>
			<div type="funding">
<div xml:id="_3Qx9M2u"><p xml:id="_pWXg7qG"><s xml:id="_EenXR5V">Funding <rs type="funder">EU</rs>'s <rs type="programName">Horizon 2020 Research and Innovation Programme</rs>.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_g8Qfe3M">SMS</head><p xml:id="_qRcJQrc"><s xml:id="_M9FppaR">Argay et al (2015) <ref type="bibr" target="#b40">37</ref> Arora et al (2014) <ref type="bibr" target="#b41">38</ref> Dobson et al (2020) <ref type="bibr" target="#b43">40</ref> Fang et al (2018) <ref type="bibr" target="#b44">41</ref> Shariful Islam et al (2015) <ref type="bibr" target="#b51">48</ref> Ramallo-Fariña et al (2020) <ref type="bibr" target="#b49">46</ref> Sadanshiv et al (2020) <ref type="bibr" target="#b50">47</ref> Whittemore et al (2020) <ref type="bibr" target="#b57">54</ref> Xu et al (2020) 55</s></p></div>
<div><head xml:id="_tAMNbh3">Subtotal (95% CI)</head><p xml:id="_UUjJd35"><s xml:id="_Gb9XA8f">Test for overall effect: Z=3•68 (p=0•0002)</s></p></div>
<div><head xml:id="_27XPxPH">Smartphone application</head><p xml:id="_TMJHkys"><s xml:id="_z6SMnM9">Omar et al (2020) <ref type="bibr" target="#b59">56</ref> Anzaldo-Campos et al (2016) <ref type="bibr" target="#b60">57</ref> Frias et al (2017) <ref type="bibr" target="#b65">62</ref> Gong et al (2020) <ref type="bibr" target="#b66">63</ref> Kleinman et al (2017) <ref type="bibr" target="#b70">67</ref> Ku et al (2020) <ref type="bibr" target="#b71">68</ref> Kumar et al (2021) <ref type="bibr" target="#b72">69</ref> Li et al (2021) <ref type="bibr" target="#b74">71</ref> Quinn et al (2016); <ref type="bibr" target="#b77">74</ref> &gt;55 years Quinn et al (2016); <rs type="grantNumber">74 ≤55</rs> years Sun et al (2019) <ref type="bibr" target="#b78">75</ref> Waki K et al (2014) <ref type="bibr" target="#b79">76</ref> Yu et al (2019) <ref type="bibr" target="#b81">78</ref></s></p></div>
<div><head xml:id="_wvbHUWJ">Zhou et al (2016) 82</head></div>
<div><head xml:id="_u5EKbB9">Subtotal (95% CI)</head><p xml:id="_EVAmCXF"><s xml:id="_NNFss3t"><rs type="projectName">Heterogeneity</rs>: <rs type="grantNumber">τ 2 =0•10</rs>; <rs type="grantNumber">χ 2 =187•74</rs>, df=13 (p&lt;0•0001); <rs type="programName">I 2 =93% Test</rs> for overall effect: <rs type="grantNumber">Z=3•84</rs> (p=0•0001)</s></p></div>
<div><head xml:id="_gZc6npJ">Website</head><p xml:id="_FEdePHN"><s xml:id="_jXQqBFX">Kim et al (2016) <ref type="bibr" target="#b89">86</ref> McLeod et al (2020) <ref type="bibr" target="#b91">88</ref> Ralston et al (2009) <ref type="bibr" target="#b93">90</ref></s></p></div>
<div><head xml:id="_W59K6hj">Ramadas et al (2018) 91</head><p xml:id="_meN3sUj"><s xml:id="_5HBErcD">Subtotal (<rs type="grantNumber">95% CI</rs>) <rs type="projectName">Heterogeneity</rs>: <rs type="grantNumber">τ 2 =0•28</rs>; <rs type="grantNumber">χ 2 =29•82</rs>, df=3 (p&lt;0•0001); <rs type="programName">I 2 =90% Test</rs> for overall effect: <rs type="grantNumber">Z=0•33 (p=0•74</rs>) Total (<rs type="grantNumber">95% Cl</rs>) <rs type="projectName">Heterogeneity</rs><rs type="grantNumber">• τ 2 =0•05</rs>, <rs type="grantNumber">χ 2 =289•56</rs>, df=26 (p&lt;0•0001); <rs type="grantNumber">I 2 =91%</rs> <rs type="projectName">Test</rs> for overall effect: <rs type="grantNumber">Z=5•34</rs> (p&lt;0•0001) Test for subqroup differences: <rs type="grantNumber">χ 2 =1•16</rs>, df=2 (p=0•<rs type="grantNumber">56</rs>); <rs type="grantNumber">I 2 =0%</rs></s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funded-project" xml:id="_CxtbDyX">
					<idno type="grant-number">945246</idno>
					<orgName type="project" subtype="full">DigiCare4You study</orgName>
					<orgName type="program" subtype="full">Horizon 2020 Research and Innovation Programme</orgName>
				</org>
				<org type="funding" xml:id="_E4rEQgh">
					<orgName type="program" subtype="full">Horizon 2020 Research and Innovation Programme</orgName>
				</org>
				<org type="funding" xml:id="_PmaFskV">
					<idno type="grant-number">74 ≤55</idno>
				</org>
				<org type="funding" xml:id="_RpyZfnR">
					<idno type="grant-number">75 Waki K</idno>
				</org>
				<org type="funded-project" xml:id="_MXJcVzt">
					<idno type="grant-number">τ 2 =0•10</idno>
					<orgName type="project" subtype="full">Heterogeneity</orgName>
				</org>
				<org type="funding" xml:id="_EbMgCQH">
					<idno type="grant-number">χ 2 =187•74</idno>
					<orgName type="program" subtype="full">I 2 =93% Test</orgName>
				</org>
				<org type="funding" xml:id="_54T4FhR">
					<idno type="grant-number">Z=3•84</idno>
				</org>
				<org type="funded-project" xml:id="_k8AcUYB">
					<idno type="grant-number">95% CI</idno>
					<orgName type="project" subtype="full">Heterogeneity</orgName>
				</org>
				<org type="funding" xml:id="_dYRBU4x">
					<idno type="grant-number">τ 2 =0•28</idno>
				</org>
				<org type="funding" xml:id="_gjeWcp4">
					<idno type="grant-number">χ 2 =29•82</idno>
					<orgName type="program" subtype="full">I 2 =90% Test</orgName>
				</org>
				<org type="funding" xml:id="_ue6jNmG">
					<idno type="grant-number">Z=0•33 (p=0•74</idno>
				</org>
				<org type="funded-project" xml:id="_qSehPFr">
					<idno type="grant-number">95% Cl</idno>
					<orgName type="project" subtype="full">Heterogeneity</orgName>
				</org>
				<org type="funding" xml:id="_a4vW3gv">
					<idno type="grant-number">• τ 2 =0•05</idno>
				</org>
				<org type="funding" xml:id="_FECzsFR">
					<idno type="grant-number">χ 2 =289•56</idno>
				</org>
				<org type="funded-project" xml:id="_hDD7q2E">
					<idno type="grant-number">I 2 =91%</idno>
					<orgName type="project" subtype="full">Test</orgName>
				</org>
				<org type="funding" xml:id="_dJHDG3W">
					<idno type="grant-number">Z=5•34</idno>
				</org>
				<org type="funding" xml:id="_P7rpWbY">
					<idno type="grant-number">χ 2 =1•16</idno>
				</org>
				<org type="funding" xml:id="_HtqwfxB">
					<idno type="grant-number">56</idno>
				</org>
				<org type="funding" xml:id="_cSayV6q">
					<idno type="grant-number">I 2 =0%</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7XGV2vF">Contributors</head><p xml:id="_ensUey9"><s xml:id="_NkjfWZS">GM and YM conceptualised the study.</s><s xml:id="_9xvQHXr">GM and GS designed the methodology.</s><s xml:id="_Fk3369n">GS, JJ, and EE did the data collection.</s><s xml:id="_EqHVkwP">GS and JJ did the data analysis.</s><s xml:id="_FMYsqek">GS supervised the data collection and analyses.</s><s xml:id="_ryxeW9t">GS and GM did project administration.</s><s xml:id="_sVuFt8s">GM, RV, RW, LA, BO, and YM acquired funding.</s><s xml:id="_qMgX2RV">GS prepared the original draft of the manuscript.</s><s xml:id="_2kdjTjN">All authors edited and reviewed the final manuscript.</s><s xml:id="_wPngvGV">All authors have read and agreed to the final version of the manuscript and to the decision to submit.</s><s xml:id="_2WMVeam">All authors had access to all the data.</s><s xml:id="_RE5z4ZR">GS and GM have verified the data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2qvtGeH">Declaration of interests</head><p xml:id="_uyKaqaJ"><s xml:id="_Jym5Jhz">LA received consulting fees from Mundipharma for advice on costeffectiveness of SGLT2 inhibitors for the management of type 2 diabetes; honoraria from Boehringer Ingelheim and from Mundipharma for lectures on health economic aspects of diabetes; and is a member of the board of the AstraZeneca Foundation.</s><s xml:id="_2qWGg5J">All other authors declare no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Y82thYK">Data sharing</head><p xml:id="_dupnpT3"><s xml:id="_RJ3a9u3">Template data collection forms, data extracted from included studies, and data used for analyses can all be made available upon request to George Siopis.</s><s xml:id="_zVk3wE8">GS, GM, and DK received funding from the National Health and Medical Research Council (NHMRC) of Australia, as part of the NHMRC European Union Collaborative Research Grant Scheme, under the agreement with the NHMRC ID APP2007006.</s><s xml:id="_g5Rttbj">GS is a recipient of an Executive Dean Health Research Fellowship from Deakin University.</s><s xml:id="_XCgCxWx">RV declares receipt by New York University Grossman School of Medicine of a DigiCare4You funding subaward.</s><s xml:id="_AHf5CGN">The content of this Article reflects only the authors' views, and the EU is not liable for any use that may be made of the information contained therein.</s><s xml:id="_nHyWDWg">The authors of this Article wish to thank the authors of included original studies in this review and their statisticians who responded to communication and provided requested information or data.</s><s xml:id="_QmQGZMC">We also thank Meteda's representatives for participating in the initial meeting of the evidence synthesis committee (authors) for the planning of the systematic review.</s><s xml:id="_DjeyvtC">Meteda is a digital health company that develops medical and nutrition software for the management of diabetes.</s><s xml:id="_QUNGEWZ">Privanova is a boutique privacy compliance and risk management consultancy.</s><s xml:id="_MasWWR3">Meteda and Privanova are part of the DigiCare4You Consortium.</s><s xml:id="_qpjDFnv">Meteda and Privanova were not involved in the protocol development; searches; data collection, extraction, analysis, or interpretation; manuscript preparation; or decision to submit the manuscript for publication.</s><s xml:id="_DAEAGcF">None of the authors in this manuscript are associated with Meteda or Privanova.</s><s xml:id="_yvSYWk9">Finally, we thank the members of the DigiCare4You Consortium.</s></p><p xml:id="_n8pFbqU"><s xml:id="_YnFDbMb">Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published text and tables.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<idno type="DOI">10.3030/945246</idno>
		<title level="m" xml:id="_28yVM6n">DigiCare4You Consortium</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">DigiCare4You Consortium</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<author>
			<persName><forename type="first">Yannis</forename><surname>Manios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Chiara</forename><surname>Seghieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Djordje</forename><surname>Djokic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Konstantinos</forename><surname>Votis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Konstantinos</forename><surname>Makrilakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lieven</forename><surname>Annemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rajesh</forename><surname>Vedanthan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sabine</forename><surname>Dupont</surname></persName>
		</author>
		<title level="m" xml:id="_c4wXE37">Centre for Research &amp; Technology Hellas (Greece): Konstantinos Votis, Sofia Segkouli</title>
		<editor>
			<persName><forename type="first">Andreas</forename><surname>Triantafyllidis</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Eleftheria</forename><surname>Polychroniou</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Ioannis</forename><surname>Paliokas</surname></persName>
		</editor>
		<meeting><address><addrLine>Australia; Ghent University (Belgium</addrLine></address></meeting>
		<imprint/>
	</monogr>
	<note>Steering Committee: Yannis Manios Baker Heart and Diabetes Institute Odysseas Kyparissis</note>
	<note type="raw_reference">Coordinator: Yannis Manios. Steering Committee: Yannis Manios, Chiara Seghieri, Djordje Djokic, Konstantinos Votis, Konstantinos Makrilakis, Lieven Annemans, Rajesh Vedanthan, Sabine Dupont. Baker Heart and Diabetes Institute (Australia): Brian Oldenburg, Dominika Kwasnicka, Enying Gong, Jenny Jung, Bernard Yeboah-Asiamah Asare, Vimarsha Kodithuwakku. Centre for Research &amp; Technology Hellas (Greece): Konstantinos Votis, Sofia Segkouli, Andreas Triantafyllidis, Eleftheria Polychroniou, Ioannis Paliokas, Odysseas Kyparissis. Ghent University (Belgium):</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_7QFhVD3">Harokopio University (Greece): Yannis Manios</title>
		<author>
			<persName><forename type="first">Lieven</forename><surname>Annemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nick</forename><surname>Verhaeghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ruben</forename><surname>Willems</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dirk</forename><forename type="middle">De</forename><surname>Craemer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_Qr7Vdgb">Maartje Roskams. International Foundation for Integrated Care</title>
		<editor>
			<persName><forename type="first">Niamh</forename><surname>Lennox-Chhugani</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Edelweiss</forename><surname>Aldasoro</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Nereide</forename><forename type="middle">A</forename><surname>Curreri</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Fiona</forename><surname>Lyne</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Darren</forename><surname>Curran</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Pilar</forename><surname>Gangas Peiró</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Alejandro</forename><surname>Gil-Salmerón</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Orla</forename><surname>Snook</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Georgina</forename><surname>Ferrer</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Niamh</forename><forename type="middle">Daly</forename><surname>Day</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Martin</forename><surname>Perrin</surname></persName>
		</editor>
		<meeting><address><addrLine>Belgium; Ireland, Netherlands, UK; Australia; Meteda (Italy</addrLine></address></meeting>
		<imprint>
			<publisher>George Moschonis, George Siopis</publisher>
		</imprint>
	</monogr>
	<note>International Diabetes Federation European Region La Trobe University</note>
	<note type="raw_reference">Lieven Annemans, Nick Verhaeghe, Ruben Willems, Dirk De Craemer. Harokopio University (Greece): Yannis Manios, Kostas Anastasiou, Konstantinos Tserpes, Christina Mavrogianni, Eva Karaglani, Electra Kalogerakou, Maria Maragkoudaki, Agathi Ntzouvani, Katerina Kontochristopoulou. International Diabetes Federation European Region (Belgium): Sabine Dupont, Elizabeth Dupont, Leo Dauzon, Maartje Roskams. International Foundation for Integrated Care (Ireland, Netherlands, UK): Niamh Lennox-Chhugani, Edelweiss Aldasoro, Nereide A. Curreri, Fiona Lyne, Darren Curran, Pilar Gangas Peiró, Alejandro Gil-Salmerón, Orla Snook, Georgina Ferrer, Niamh Daly Day, Martin Perrin. La Trobe University (Australia): George Moschonis, George Siopis. Meteda (Italy):</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<author>
			<persName><forename type="first">Nazzareno</forename><surname>Pierantozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Claudia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Giacomo</forename><surname>Antonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Teresa</forename><surname>Vespasiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Helen</forename><surname>Almonti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tracy</forename><surname>Skouteris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Melissa</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><surname>Savaglio ; Konstantinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">George</forename><surname>Makrilakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stavros</forename><surname>Stergiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">George</forename><surname>Liatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chrysi</forename><surname>Karamanakos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anastasios</forename><surname>Koliaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Eva</forename><surname>Kollias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Haris</forename><surname>Zikou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Dimosthenopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Francesca</forename><surname>Ferre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anna</forename><surname>Noci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nadia</forename><surname>Bozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dina</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rachele</forename><surname>Borelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Constanza</forename><surname>Tortu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Virginia</forename><surname>Atanasova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sonya</forename><surname>Koleva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vanya</forename><surname>Marinova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vanya</forename><surname>Russeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anna</forename><surname>Kozhuharova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Luis Moreno Aznar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rosa</forename><forename type="middle">Magallón</forename><surname>Botaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gloria</forename><forename type="middle">Bueno</forename><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pilar</forename><surname>De Miguel-Etayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Esther</forename><forename type="middle">Ma</forename><surname>Gonzalez-Gil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">María</forename><forename type="middle">L</forename><surname>Miguel-Berges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Natalia</forename><surname>Giménez-Legarre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oliván</forename><surname>Bárbara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Susana</forename><surname>Blázquez</surname></persName>
		</author>
		<author>
			<persName><surname>Pérez</surname></persName>
		</author>
		<title level="m" xml:id="_XeaStfb">Medical University of Varna (Bulgaria): Violeta Iotova, Yoto</title>
		<editor>
			<persName><forename type="first">Florian</forename><surname>Toti</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Skerdi</forename><surname>Prifti</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Blerina</forename><surname>Bombaj</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Luftime</forename><surname>Bruka</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Adriana</forename><surname>Lapardhaja</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Ornela</forename><surname>Laze</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Ditila</forename><surname>Doracaj</surname></persName>
		</editor>
		<meeting><address><addrLine>Australia; Greece; Spain; Tirana (Albania</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Monash University ; National and Kapodistrian University of Athens ; University Grossman School of Medicine ; University of Medicine</orgName>
		</respStmt>
	</monogr>
	<note>Anna School of Advanced Studies Universidad De Zaragoza</note>
	<note type="raw_reference">Nazzareno Pierantozzi, Claudia D&apos;Antonio, Giacomo Vespasiani, Teresa Almonti. Monash University (Australia): Helen Skouteris, Tracy Taylor, Melissa Savaglio. National and Kapodistrian University of Athens (Greece): Konstantinos Makrilakis, George Stergiou, Stavros Liatis, George Karamanakos, Chrysi Koliaki, Anastasios Kollias, Eva Zikou, Haris Dimosthenopoulos. New York University Grossman School of Medicine (USA): Rajesh Vedanthan, Keng-Yen Huang, Samrachana Adhikari, Kun Qian, Julia Dickhaus, Kimberly Carney, Evette Eweka. Privanova (France): Farhan Sahito, Dusan Pavlovic, Djordje Djokic, Arzoo Sahito, Gisella Battalova. Sant&apos;Anna School of Advanced Studies (Italy): Chiara Seghieri, Sabina Nutti, Milena Vanieri, Nicola Belle, Gaia Bertarelli, Paola Cantarelli, Francesca Ferre, Anna Noci, Nadia Bozzi, Dina Ferrari, Rachele Borelli, Constanza Tortu. Medical University of Varna (Bulgaria): Violeta Iotova, Yoto Yotov, Natalia Usheva, Kaloyan Tsochev, Tanya Stefanova, Virginia Atanasova, Sonya Koleva, Vanya Marinova, Vanya Russeva, Anna Kozhuharova. Universidad De Zaragoza (Spain): Luis Moreno Aznar, Rosa Magallón Botaya, Gloria Bueno Lozano, Pilar De Miguel-Etayo, Esther Ma Gonzalez-Gil, María L. Miguel-Berges, Natalia Giménez-Legarre, Bárbara Oliván Blázquez, Susana Pérez. University of Medicine, Tirana (Albania): Florian Toti, Skerdi Prifti, Blerina Bombaj, Luftime Bruka, Adriana Lapardhaja, Ornela Laze, Ditila Doracaj. References</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main" xml:id="_gyr2yD9">Diabetes fact sheet</title>
		<author>
			<persName><surname>Who</surname></persName>
		</author>
		<ptr target="https://www.who.int/news-room/fact-sheets/detail/diabetes" />
		<imprint>
			<date type="published" when="2022-11-18">2022. Nov 18, 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO. Diabetes fact sheet. 2022. https://www.who.int/news-room/ fact-sheets/detail/diabetes (accessed Nov 18, 2022).</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_DN5rXK3">The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bommer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Heesemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sagalova</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2213-8587(17)30097-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UUQwwJu">Lancet Diabetes Endocrinol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="423" to="430" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017; 5: 423-30.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_n5xPTaA">Blood sugar regulation for cardiovascular health promotion and disease prevention: JACC health promotion series</title>
		<author>
			<persName><forename type="first">Peh</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Timpel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Harst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WnUKSJJ">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="1829" to="1844" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schwarz PEH, Timpel P, Harst L, et al. Blood sugar regulation for cardiovascular health promotion and disease prevention: JACC health promotion series. J Am Coll Cardiol 2018; 72: 1829-44.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_6WFJmCN">Summary of revisions: standards of medical care in diabetes-2021</title>
		<author>
			<persName><forename type="first">American</forename><surname>Diabetes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Association</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5KMy979">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">suppl 1</biblScope>
			<biblScope unit="page" from="4" to="6" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">American Diabetes Association. Summary of revisions: standards of medical care in diabetes-2021. Diabetes Care 2021; 44 (suppl 1): S4-6.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_tUdXdDe">national standards for diabetes self-management education and support</title>
		<author>
			<persName><forename type="first">J</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Greenwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Blanton</surname></persName>
		</author>
		<idno type="DOI">10.2337/dci17-0025</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vj47Mxb">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1409" to="1419" />
			<date type="published" when="2017">2017. 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beck J, Greenwood DA, Blanton L, et al. 2017 national standards for diabetes self-management education and support. Diabetes Care 2017; 40: 1409-19.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_cvbuBBr">A systematic review of reviews evaluating technology-enabled diabetes self-management education and support</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Greenwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Fatkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peeples</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ux988Jf">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1015" to="1027" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Greenwood DA, Gee PM, Fatkin KJ, Peeples M. A systematic review of reviews evaluating technology-enabled diabetes self-management education and support. J Diabetes Sci Technol 2017; 11: 1015-27.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_cJ3XpaF">Telehealth for diabetes self-management in primary healthcare: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Chung</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x17700552</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qPQeSbm">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="356" to="364" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">So CF, Chung JW. Telehealth for diabetes self-management in primary healthcare: a systematic review and meta-analysis. J Telemed Telecare 2018; 24: 356-64.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_QBAv35p">Telemedicine in complex diabetes management</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Mcdonnell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vhSDgyC">Curr Diab Rep</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">42</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDonnell ME. Telemedicine in complex diabetes management. Curr Diab Rep 2018; 18: 42.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<author>
			<persName><surname>Spinfold</surname></persName>
		</author>
		<ptr target="https://www.spinfold.com/first-touchscreen-phone/" />
		<title level="m" xml:id="_FPK3CNm">History of first touchscreen phone</title>
		<imprint>
			<date type="published" when="2022-11-18">Nov 18, 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">SpinFold. History of first touchscreen phone. https://www.spinfold. com/first-touchscreen-phone/ (accessed Nov 18, 2022).</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main" xml:id="_yAWaU2N">How many smartphones are in the world?</title>
		<author>
			<persName><surname>Bankmycell</surname></persName>
		</author>
		<author>
			<persName><surname>Com</surname></persName>
		</author>
		<ptr target="https://www.bankmycell.com/blog/how-many-phones-are-in-the-world" />
		<imprint>
			<date type="published" when="2021-01-14">2021. Jan 14, 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bankmycell.com. How many smartphones are in the world? 2021. https://www.bankmycell.com/blog/how-many-phones-are-in-the- world (accessed Jan 14, 2023).</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main" xml:id="_uuuHdSN">Telehealth systems</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Mechanic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Persaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Kimball</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
			<publisher>StatPearls Publishing</publisher>
			<pubPlace>Treasure Island, FL</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Mechanic OJ, Persaud Y, Kimball AB. Telehealth systems. Treasure Island, FL: StatPearls Publishing, 2020.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_ZXgHhhN">Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review</title>
		<author>
			<persName><forename type="first">F</forename><surname>Verhoeven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tanja</forename><forename type="middle">-</forename><surname>Dijkstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nijland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Eysenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Gemert-Pijnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GMpGp5E">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="666" to="684" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L. Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol 2010; 4: 666-84.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_kf2dYxw">A systematic review of reviews evaluating technology-enabled diabetes self-management education and support</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Greenwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Fatkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peeples</surname></persName>
		</author>
		<idno type="DOI">10.1177/1932296817713506</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_egt28mt">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1015" to="1027" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Greenwood DA, Gee PM, Fatkin KJ, Peeples M. A systematic review of reviews evaluating technology-enabled diabetes self-management education and support. J Diabetes Sci Technol 2017; 11: 1015-27.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_JKq7E8M">Effectiveness of mHealth interventions for patients with diabetes: an overview of systematic reviews</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kitsiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Paré</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jaana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gerber</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0173160</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X3qw3UB">PLoS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">173160</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kitsiou S, Paré G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: an overview of systematic reviews. PLoS One 2017; 12: e0173160.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_GxRAeZA">A systematic review on incentive-driven mobile health technology: as used in diabetes management</title>
		<author>
			<persName><forename type="first">M</forename><surname>De Ridder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Khadra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nanan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u232fTh">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="26" to="35" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Ridder M, Kim J, Jing Y, Khadra M, Nanan R. A systematic review on incentive-driven mobile health technology: as used in diabetes management. J Telemed Telecare 2017; 23: 26-35.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_Nvrj48k">The effectiveness of text message-based self-management interventions for poorly-controlled diabetes: a systematic review</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pfaeffli</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Maddison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yR9Hdnk">Digit Health</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">2055207617740315</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dobson R, Whittaker R, Pfaeffli Dale L, Maddison R. The effectiveness of text message-based self-management interventions for poorly-controlled diabetes: a systematic review. Digit Health 2017; 3: 2055207617740315.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_Dvn5NhS">What do we know about mobile applications for diabetes selfmanagement? A review of reviews</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Corsica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chirinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vivo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FDeKJFd">J Behav Med</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="981" to="994" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hood M, Wilson R, Corsica J, Bradley L, Chirinos D, Vivo A. What do we know about mobile applications for diabetes self- management? A review of reviews. J Behav Med 2016; 39: 981-94.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_2kbbZxv">Internet interventions to support lifestyle modification for diabetes management: a systematic review of the evidence</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Cotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Durant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Agne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Cherrington</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2b5NSmD">J Diabetes Complications</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="243" to="251" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cotter AP, Durant N, Agne AA, Cherrington AL. Internet interventions to support lifestyle modification for diabetes management: a systematic review of the evidence. J Diabetes Complications 2014; 28: 243-51.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_Gbz66XE">The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mckenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bossuyt</surname></persName>
		</author>
		<idno type="DOI">10.31222/osf.io/jb4dx</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k9fTyY5">BMJ</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page">71</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_TM4pT87">Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trials</title>
		<author>
			<persName><forename type="first">G</forename><surname>Siopis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Moschonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eweka</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.hjh.0000913356.83879.cf</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xUyeyC4">Lancet Digit Health</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="144" to="159" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siopis G, Moschonis G, Eweka E, et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trials. Lancet Digit Health 2023 5: e144-59.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_X5fyDzT">Perspectives on the evolution of mobile (mHealth) technologies and application to rehabilitation</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Dicianno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Parmanto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Fairman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vJTqAb6">Phys Ther</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="397" to="405" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dicianno BE, Parmanto B, Fairman AD, et al. Perspectives on the evolution of mobile (mHealth) technologies and application to rehabilitation. Phys Ther 2015; 95: 397-405.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main" xml:id="_CsKRast">Cochrane handbook for systematic reviews of interventions version 6.0</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chandler</surname></persName>
		</author>
		<ptr target="https://training.cochrane.org/handbook/archive/v6" />
		<imprint>
			<date type="published" when="2019-11-18">2019. Nov 18, 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.0. 2019. https:// training.cochrane.org/handbook/archive/v6 (accessed Nov 18, 2022).</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_AH9xUqq">Differences in interpretation of haemoglobin A1c values among diabetes care professionals</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lenters-Westra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Schindhelm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Bilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Groenier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Slingerland</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2012.10.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_U7e6R2M">Neth J Med</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="462" to="466" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lenters-Westra E, Schindhelm RK, Bilo HJ, Groenier KH, Slingerland RJ. Differences in interpretation of haemoglobin A1c values among diabetes care professionals. Neth J Med 2014; 72: 462-66.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_jcPNj7s">RoB 2: a revised tool for assessing risk of bias in randomised trials</title>
		<author>
			<persName><forename type="first">Jac</forename><surname>Sterne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Savović</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Page</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BRXfzHg">BMJ</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page">4898</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m" type="main" xml:id="_SuKyCrX">Cochrane handbook for systematic reviews of interventions version 5</title>
		<author>
			<persName><forename type="first">Jpt</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</author>
		<idno type="DOI">10.1002/9780470712184</idno>
		<idno>.1.0</idno>
		<ptr target="https://training.cochrane.org/handbook/archive/v5.1/" />
		<imprint>
			<date type="published" when="2011-11-18">2011. Nov 18, 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. 2011. https://training.cochrane.org/ handbook/archive/v5.1/ (accessed Nov 18, 2022).</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_wf4DGzU">Meta-analysis in clinical trials</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dersimonian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Laird</surname></persName>
		</author>
		<idno type="DOI">10.1016/0197-2456(86)90046-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aWdA8zE">Contr Clin Trials</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="177" to="e88" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials. 1986; 7: 177e88.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_xzsRSYC">Measuring inconsistency in meta-analyses</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Deeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_q3gmmQR">BMJ</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="page" from="557" to="e60" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557e60.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main" xml:id="_VwCXDNZ">Grade Series</title>
		<ptr target="https://www.jclinepi.com/content/jce-GRADE-Series" />
		<imprint>
			<date type="published" when="2019-11-18">2019. Nov 18, 2022</date>
			<publisher>Grade Working Group</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Grade Working Group. Grade Series. 2019. https://www.jclinepi. com/content/jce-GRADE-Series. (accessed Nov 18, 2022).</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_SZyS4pc">GRADE guidelines: 7. Rating the quality of evidence-inconsistency</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kunz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZYtB6fX">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1294" to="1302" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 2011; 64: 1294-302.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_F3wbyR3">GRADE guidelines 6. Rating the quality of evidence-imprecision</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kunz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2011.01.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tzUCPC3">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1283" to="1293" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011; 64: 1283-93.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_5u3XXbc">GRADE guidelines: 3. Rating the quality of evidence</title>
		<author>
			<persName><forename type="first">H</forename><surname>Balshem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Helfand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schünemann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2010.07.015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6hsDRzp">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="401" to="406" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-06.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_mYAUsjW">Process evaluation of complex interventions: Medical Research Council guidance</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Audrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barker</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.h1258</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fK449Ut">BMJ</title>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="page">1258</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015; 350: h1258.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_gM2qBYc">A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance</title>
		<author>
			<persName><forename type="first">K</forename><surname>Skivington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Simpson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.n2061</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k2m8ptc">BMJ</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="page">2061</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ 2021; 374: n2061.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_TW4wtRf">Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda</title>
		<author>
			<persName><forename type="first">E</forename><surname>Proctor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Silmere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raghavan</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10488-010-0319-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tUgkUjh">Adm Policy Ment Health</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="65" to="76" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health 2011; 38: 65-76.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_pUatQ96">RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Glasgow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Harden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gaglio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MW8UuxF">Front Public Health</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">64</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Glasgow RE, Harden SM, Gaglio B, et al. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health 2019; 7: 64.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_gjdzvz8">SMS education for the promotion of diabetes self-management in low &amp; middle income countries: a pilot randomized controlled trial in Egypt</title>
		<author>
			<persName><forename type="first">H</forename><surname>Abaza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marschollek</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12889-017-4973-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8rZUdEd">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">962</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abaza H, Marschollek M. SMS education for the promotion of diabetes self-management in low &amp; middle income countries: a pilot randomized controlled trial in Egypt. BMC Public Health 2017; 17: 962.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_a3rUvpA">Therapy reminder message for Hungarian patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Argay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meskó</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zelkó</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hankó</surname></persName>
		</author>
		<idno type="DOI">10.5414/cp201592</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G3jaZTk">Acta Pol Pharm</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="1289" to="1293" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Argay M, Meskó A, Zelkó R, Hankó B. Therapy reminder message for Hungarian patients with type 2 diabetes. Acta Pol Pharm 2015; 72: 1289-93.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_kfaSUvD">Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Arora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Burner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Menchine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9gFtz7r">Ann Emerg Med</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="745" to="754" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med 2014; 63: 745-54.e6.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_S6zg2tF">Going mobile with diabetes support: a randomized study of a text message-based personalized behavioral intervention for type 2 diabetes self-care</title>
		<author>
			<persName><forename type="first">K</forename><surname>Capozza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Woolsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Georgsson</surname></persName>
		</author>
		<idno type="DOI">10.2337/diaspect.28.2.83</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mjBUuW2">Diabetes Spectr</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="83" to="91" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Capozza K, Woolsey S, Georgsson M, et al. Going mobile with diabetes support: a randomized study of a text message-based personalized behavioral intervention for type 2 diabetes self-care. Diabetes Spectr 2015; 28: 83-91.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_jYaFMEa">Long-term follow-up of a randomized controlled trial of a text-message diabetes selfmanagement support programme, SMS4BG</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BXt4huC">Diabet Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="311" to="318" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dobson R, Whittaker R, Jiang Y, et al. Long-term follow-up of a randomized controlled trial of a text-message diabetes self- management support programme, SMS4BG. Diabet Med 2020; 37: 311-18.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_je6XwyM">Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Deng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xAvnnEd">J Clin Nurs</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="612" to="620" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fang R, Deng X. Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: a randomised controlled trial. J Clin Nurs 2018; 27: 612-20.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_xvQAfvK">Dulce Digital: an mHealth SMS-based intervention improves glycemic control in Hispanics with type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Fortmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Garcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2MqvHyZ">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1349" to="1355" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fortmann AL, Gallo LC, Garcia MI, et al. Dulce Digital: an mHealth SMS-based intervention improves glycemic control in Hispanics with type 2 diabetes. Diabetes Care 2017; 40: 1349-55.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_BHNfZ7P">Impact of distance education via mobile phone text messaging on knowledge, attitude, practice and self efficacy of patients with type 2 diabetes mellitus in Iran</title>
		<author>
			<persName><forename type="first">M</forename><surname>Goodarzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ebrahimzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rabi</forename><forename type="middle">A</forename><surname>Saedipoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jafarabadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1186/2251-6581-11-10</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_d9SPten">J Diabetes Metab Disord</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">10</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodarzi M, Ebrahimzadeh I, Rabi A, Saedipoor B, Jafarabadi MA. Impact of distance education via mobile phone text messaging on knowledge, attitude, practice and self efficacy of patients with type 2 diabetes mellitus in Iran. J Diabetes Metab Disord 2012; 11: 10.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_fFYF4EC">Insulin dose titration system in diabetes patients using a short messaging service automatically produced by a knowledge matrix</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Kang</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2010.0031</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xkbk7Wd">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="663" to="669" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kim CS, Park SY, Kang JG, et al. Insulin dose titration system in diabetes patients using a short messaging service automatically produced by a knowledge matrix. Diabetes Technol Ther 2010; 12: 663-69.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_aAgY27a">Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shin</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc10-1447</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tESxt43">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="308" to="313" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lim S, Kang SM, Shin H, et al. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care 2011; 34: 308-13.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_CZPdAeh">Effectiveness of internet-based multicomponent interventions for patients and health care professionals to improve clinical outcomes in type 2 diabetes evaluated through the INDICA study: multiarm cluster randomized controlled trial</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ramallo-Fariña</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>García-Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>García-Pérez</surname></persName>
		</author>
		<idno type="DOI">10.2196/18922</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hxWhvBt">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e18922</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ramallo-Fariña Y, García-Bello MA, García-Pérez L, et al. Effectiveness of internet-based multicomponent interventions for patients and health care professionals to improve clinical outcomes in type 2 diabetes evaluated through the INDICA study: multiarm cluster randomized controlled trial. JMIR Mhealth Uhealth 2020; 8: e18922.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_vJtNrgM">Feasibility of computer-generated telephonic message-based follow-up system among healthcare workers with diabetes: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sadanshiv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jeyaseelan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kirupakaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sonwani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Sudarsanam</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjdrc-2020-001237</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R3sK7BH">BMJ Open Diabetes Res Care</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e001237</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sadanshiv M, Jeyaseelan L, Kirupakaran H, Sonwani V, Sudarsanam TD. Feasibility of computer-generated telephonic message-based follow-up system among healthcare workers with diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 2020; 8: e001237.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_XAyJ5Xr">Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial</title>
		<author>
			<persName><forename type="first">Shariful</forename><surname>Islam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Niessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Seissler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lechner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gbAg7GY">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="112" to="113" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shariful Islam SM, Niessen LW, Ferrari U, Ali L, Seissler J, Lechner A. Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial. Diabetes Care 2015; 38: e112-13.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_syZNNf3">Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: a feasibility study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Peimani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rambod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Omidvar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JpQqZK4">Prim Care Diabetes</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="251" to="258" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peimani M, Rambod C, Omidvar M, et al. Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: a feasibility study. Prim Care Diabetes 2016; 10: 251-58.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_fzSMJZ9">Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)-a pilot study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Shetty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chamukuttan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nanditha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Raj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ramachandran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_peGWk6h">J Assoc Physicians India</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="711" to="714" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shetty AS, Chamukuttan S, Nanditha A, Raj RK, Ramachandran A. Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)-a pilot study. J Assoc Physicians India 2011; 59: 711-14.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_dxzuk6n">Use of short message services (SMS) for the management of type 2 diabetes mellitus: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tamban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Isip-Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jimeno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JkhMVbM">J ASEAN Fed Endocr Soc</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="143" to="149" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tamban C, Isip-Tan IT, Jimeno C. Use of short message services (SMS) for the management of type 2 diabetes mellitus: a randomized controlled trial. J ASEAN Fed Endocr Soc 2014; 28: 143-49.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_dNHqh9H">Effectiveness of mobile phone text messaging in improving glycaemic control among persons with newly detected type 2 diabetes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Vinitha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nanditha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Snehalatha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pq8f4Eg">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page">107919</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vinitha R, Nanditha A, Snehalatha C, et al. Effectiveness of mobile phone text messaging in improving glycaemic control among persons with newly detected type 2 diabetes. Diabetes Res Clin Pract 2019; 158: 107919.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_vhuCewe">SMS-based intervention in type 2 diabetes: clinical trial in Senegal</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wargny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kleinebreil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Diop</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjinnov-2018-000278</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gZFB5ba">BMJ Innov</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="142" to="146" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wargny M, Kleinebreil L, Diop SN, et al. SMS-based intervention in type 2 diabetes: clinical trial in Senegal. BMJ Innov 2018; 4: 142-46.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_vQXXz9J">Yo Puedo Vivir Sano con Diabetes! A self-management randomized controlled pilot trial for low-income adults with type 2 diabetes in Mexico City</title>
		<author>
			<persName><forename type="first">R</forename><surname>Whittemore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vilar-Compte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cerda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XHhSyEe">Curr Dev Nutr</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">74</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whittemore R, Vilar-Compte M, De La Cerda S, et al. ¡Sí, Yo Puedo Vivir Sano con Diabetes! A self-management randomized controlled pilot trial for low-income adults with type 2 diabetes in Mexico City. Curr Dev Nutr 2020; 4: nzaa074.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_w3XgdUx">Improving HbA 1c with glucose self-monitoring in diabetic patients with EpxDiabetes, a phone call and text message-based telemedicine platform: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Javaherian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bernal-Mizrachi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4vjGy8p">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="784" to="793" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Xu R, Xing M, Javaherian K, Peters R, Ross W, Bernal-Mizrachi C. Improving HbA 1c with glucose self-monitoring in diabetic patients with EpxDiabetes, a phone call and text message-based telemedicine platform: a randomized controlled trial. Telemed J E Health 2020; 26: 784-93.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_US3P8HP">The impact of a self-management educational program coordinated through WhatsApp on diabetes control</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Omar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Palaian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mahameed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v7aURAj">Pharm Pract</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">1841</biblScope>
			<date type="published" when="2020">2020</date>
			<pubPlace>Granada</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Omar MA, Hasan S, Palaian S, Mahameed S. The impact of a self-management educational program coordinated through WhatsApp on diabetes control. Pharm Pract (Granada) 2020; 18: 1841.</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_48dkHuQ">Dulce wireless Tijuana: a randomized control trial evaluating the impact of project Dulce and short-term mobile technology on glycemic control in a family medicine clinic in Northern Mexico</title>
		<author>
			<persName><forename type="first">Anzaldo-Campos</forename><surname>Mc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Contreras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vargas-Ojeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Menchaca-Díaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fortmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Philis</forename><forename type="middle">-</forename><surname>Tsimikas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a6QQsDP">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="240" to="251" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Anzaldo-Campos MC, Contreras S, Vargas-Ojeda A, Menchaca-Díaz R, Fortmann A, Philis-Tsimikas A. Dulce wireless Tijuana: a randomized control trial evaluating the impact of project Dulce and short-term mobile technology on glycemic control in a family medicine clinic in Northern Mexico. Diabetes Technol Ther 2016; 18: 240-51.</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_Cy7UUrz">A feasible and efficacious mobile-phone based lifestyle intervention for Filipino Americans with type 2 diabetes: randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Padash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZwfEJTf">JMIR Diabetes</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">e30</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bender MS, Cooper BA, Park LG, Padash S, Arai S. A feasible and efficacious mobile-phone based lifestyle intervention for Filipino Americans with type 2 diabetes: randomized controlled trial. JMIR Diabetes 2017; 2: e30.</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_Yq6Ug4Y">Enhanced self-efficacy and behavioral changes among patients with diabetes: cloud-based mobile health platform and mobile app service</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_d5PN6NV">JMIR Diabetes</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e11017</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chao DY, Lin TM, Ma WY. Enhanced self-efficacy and behavioral changes among patients with diabetes: cloud-based mobile health platform and mobile app service. JMIR Diabetes 2019; 4: e11017.</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_2bc6XQN">Increased self-care activities and glycemic control rate in relation to health education via Wechat among diabetes patients: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Dai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mFAjhhM">Medicine</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page">13632</biblScope>
			<date type="published" when="2018">2018</date>
			<pubPlace>Baltimore</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Dong Y, Wang P, Dai Z, et al. Increased self-care activities and glycemic control rate in relation to health education via Wechat among diabetes patients: a randomized clinical trial. Medicine (Baltimore) 2018; 97: e13632.</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_s7PxWnA">DIABEO system combining a mobile app software with and without telemonitoring versus standard care: a randomized controlled trial in diabetes patients poorly controlled with a basal-bolus insulin regimen</title>
		<author>
			<persName><forename type="first">S</forename><surname>Franc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hanaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Benhamou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dTWJRsK">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="904" to="911" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Franc S, Hanaire H, Benhamou PY, et al. DIABEO system combining a mobile app software with and without telemonitoring versus standard care: a randomized controlled trial in diabetes patients poorly controlled with a basal-bolus insulin regimen. Diabetes Technol Ther 2020; 22: 904-11.</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_gp8XHWq">Effectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes: prospective, openlabel, cluster-randomized pilot clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Frias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Virdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Raja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Savage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Osterberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9q2pZ2w">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">246</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Frias J, Virdi N, Raja P, Kim Y, Savage G, Osterberg L. Effectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes: prospective, open- label, cluster-randomized pilot clinical trial. J Med Internet Res 2017; 19: e246.</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_U4wvES8">My Diabetes Coach, a mobile app-based interactive conversational agent to support type 2 diabetes self-management: randomized effectivenessimplementation trial</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baptista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Russell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wTJNRs7">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">20322</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gong E, Baptista S, Russell A, et al. My Diabetes Coach, a mobile app-based interactive conversational agent to support type 2 diabetes self-management: randomized effectiveness- implementation trial. J Med Internet Res 2020; 22: e20322.</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_hqnsk8h">The influence of the smart glucose manager mobile application on diabetes management</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Gunawardena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Robinett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bcpW6hz">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="75" to="81" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gunawardena KC, Jackson R, Robinett I, et al. The influence of the smart glucose manager mobile application on diabetes management. J Diabetes Sci Technol 2019; 13: 75-81.</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_cxVf3KR">A digital lifestyle program in outpatient treatment of type 2 diabetes: a randomized controlled study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hilmarsdóttir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Á</forename><forename type="middle">K</forename><surname>Sigurðardóttir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Arnardóttir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5bcQ4wQ">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1134" to="1141" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hilmarsdóttir E, Sigurðardóttir ÁK, Arnardóttir RH. A digital lifestyle program in outpatient treatment of type 2 diabetes: a randomized controlled study. J Diabetes Sci Technol 2021; 15: 1134-41.</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_F8YQ2CF">Impact of the Gather mHealth system on A1c: primary results of a multisite randomized clinical trial among people with type 2 diabetes in India</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Kleinman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Phatak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Viswanathan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CUnM224">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="169" to="170" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Impact of the Gather mHealth system on A1c: primary results of a multisite randomized clinical trial among people with type 2 diabetes in India. Diabetes Care 2016; 39: e169-70.</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_rExYBKP">Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Kleinman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Phatak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Viswanathan</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2016.0265</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JmtZe36">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="733" to="740" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemed J E Health 2017; 23: 733-40.</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_a647Axg">Clinical efficacy and plausibility of a smartphone-based integrated online real-time diabetes care system via glucose and diet data management: a pilot study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Ku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3M7NF8g">Intern Med J</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1524" to="1532" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ku EJ, Park JI, Jeon HJ, Oh T, Choi HJ. Clinical efficacy and plausibility of a smartphone-based integrated online real-time diabetes care system via glucose and diet data management: a pilot study. Intern Med J 2020; 50: 1524-32.</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_n8Ag8aU">Technological innovations to improve health outcome in type 2 diabetes mellitus: a randomized controlled study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Prakash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Subhash</forename><surname>Chandra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zXWwnpW">Clin Epidemiol Glob Health</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="53" to="56" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kumar DS, Prakash B, Subhash Chandra BJ, et al. Technological innovations to improve health outcome in type 2 diabetes mellitus: a randomized controlled study. Clin Epidemiol Glob Health 2021; 9: 53-56.</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_XchWufZ">Effect of voluntary participation on mobile health care in diabetes management: randomized controlled open-label trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hrJAVRb">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e19153</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee DY, Yoo SH, Min KP, Park CY. Effect of voluntary participation on mobile health care in diabetes management: randomized controlled open-label trial. JMIR Mhealth Uhealth 2020; 8: e19153.</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main" xml:id="_TkPW499">Efficiency of an mHealth app and chestwearable remote exercise monitoring intervention in patients with type 2 diabetes: a prospective, multicenter randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HrYSHHJ">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">23338</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li J, Wei D, Liu S, et al. Efficiency of an mHealth app and chest- wearable remote exercise monitoring intervention in patients with type 2 diabetes: a prospective, multicenter randomized controlled trial. JMIR Mhealth Uhealth 2021; 9: e23338.</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main" xml:id="_7Zr6Amq">Internet-based medication management services improve glycated hemoglobin levels in patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hmRx67F">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="686" to="693" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lu Z, Li Y, He Y, et al. Internet-based medication management services improve glycated hemoglobin levels in patients with type 2 diabetes. Telemed J E Health 2021; 27: 686-93.</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main" xml:id="_NyF7GKp">Improving self-care in patients with coexisting type 2 diabetes and hypertension by technological surrogate nursing: randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Or</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mkp</forename><surname>So</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RCFVk7j">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">16769</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Or CK, Liu K, So MKP, et al. Improving self-care in patients with coexisting type 2 diabetes and hypertension by technological surrogate nursing: randomized controlled trial. J Med Internet Res 2020; 22: e16769.</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main" xml:id="_wYbFx7w">Mobile diabetes intervention for glycemic control in 45-to 64-year-old persons with type 2 diabetes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Shardell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Terrin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v3yHyjp">J Appl Gerontol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="227" to="243" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Quinn CC, Shardell MD, Terrin ML, et al. Mobile diabetes intervention for glycemic control in 45-to 64-year-old persons with type 2 diabetes. J Appl Gerontol 2016; 35: 227-43.</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main" xml:id="_Bghq7eS">Mobile phone-based telemedicine practice in older Chinese patients with type 2 diabetes mellitus: randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Drma9ZC">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e10664</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sun C, Sun L, Xi S, et al. Mobile phone-based telemedicine practice in older Chinese patients with type 2 diabetes mellitus: randomized controlled trial. JMIR Mhealth Uhealth 2019; 7: e10664.</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main" xml:id="_62PhsgQ">DialBetics: a novel smartphone-based self-management support system for type 2 diabetes patients</title>
		<author>
			<persName><forename type="first">K</forename><surname>Waki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Uchimura</surname></persName>
		</author>
		<idno type="DOI">10.1177/1932296814526495</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_E7hBGUE">J Diabetes Sci Technol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="209" to="215" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Waki K, Fujita H, Uchimura Y, et al. DialBetics: a novel smartphone-based self-management support system for type 2 diabetes patients. J Diabetes Sci Technol 2014; 8: 209-15.</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main" xml:id="_XUaJvsF">Effects of continuous care for patients with type 2 diabetes using mobile health application: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GbEufPc">Int J Health Plann Manage</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1025" to="1035" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang Y, Li M, Zhao X, et al. Effects of continuous care for patients with type 2 diabetes using mobile health application: a randomised controlled trial. Int J Health Plann Manage 2019; 34: 1025-35.</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main" xml:id="_jJcnYtJ">Effects of mobile phone application combined with or without self-monitoring of blood glucose on glycemic control in patients with diabetes: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DsJMN9w">J Diabetes Investig</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1365" to="1371" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yu Y, Yan Q, Li H, et al. Effects of mobile phone application combined with or without self-monitoring of blood glucose on glycemic control in patients with diabetes: a randomized controlled trial. J Diabetes Investig 2019; 10: 1365-71.</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main" xml:id="_zUq8ap9">Efficacy of an electronic health management program for patients with cardiovascular risk: randomized controlled trial</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Yun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Cho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qyRpbbV">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">15057</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yun YH, Kang E, Cho YM, et al. Efficacy of an electronic health management program for patients with cardiovascular risk: randomized controlled trial. J Med Internet Res 2020; 22: e15057.</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main" xml:id="_DCyfCpG">Effectiveness of smartphone app-based interactive management on glycemic control in Chinese patients with poorly controlled diabetes: randomized controlled trial</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
		<idno type="DOI">10.2196/15401</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rUUt5zQ">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">15401</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang L, He X, Shen Y, et al. Effectiveness of smartphone app-based interactive management on glycemic control in Chinese patients with poorly controlled diabetes: randomized controlled trial. J Med Internet Res 2019; 21: e15401.</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main" xml:id="_MRDMcBz">A randomized controlled trial of a smart phone-based diabetes management application to improve blood glucose control in Chinese people with diabetes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qZqwGhN">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang L, He X, Shen Y, et al. A randomized controlled trial of a smart phone-based diabetes management application to improve blood glucose control in Chinese people with diabetes. J Med Internet Res 2019; 9: 140.</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main" xml:id="_ehFyUUJ">Welltang -a smart phone-based diabetes management application -improves blood glucose control in Chinese people with diabetes</title>
		<author>
			<persName><forename type="first">W</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_twexVZS">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="105" to="110" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhou W, Chen M, Yuan J, Sun Y. Welltang -a smart phone-based diabetes management application -improves blood glucose control in Chinese people with diabetes. Diabetes Res Clin Pract 2016; 116: 105-10.</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main" xml:id="_RgJGw96">A fully automated web-based program improves lifestyle habits and HbA1c in patients with type 2 diabetes and abdominal obesity: randomized trial of patient e-coaching nutritional support (the ANODE study)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hansel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Giral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gambotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_b7nueus">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">360</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hansel B, Giral P, Gambotti L, et al. A fully automated web-based program improves lifestyle habits and HbA1c in patients with type 2 diabetes and abdominal obesity: randomized trial of patient e-coaching nutritional support (the ANODE study). J Med Internet Res 2017; 19: e360.</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main" xml:id="_WMtbN8a">Effectiveness of technologically enhanced peer support in improving glycemic management among predominantly African American, low-income adults with diabetes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Heisler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Reeves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PHF3uBv">Diabetes Educ</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="260" to="271" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Heisler M, Choi H, Mase R, Long JA, Reeves PJ. Effectiveness of technologically enhanced peer support in improving glycemic management among predominantly African American, low-income adults with diabetes. Diabetes Educ 2019; 45: 260-71.</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main" xml:id="_AuQVBCh">Effectiveness of a self-management support program for Thais with type 2 diabetes: evaluation according to the RE-AIM framework</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jaipakdee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jiamjarasrangsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lohsoonthorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lertmaharit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pr7JzCZ">Nurs Health Sci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="362" to="369" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jaipakdee J, Jiamjarasrangsi W, Lohsoonthorn V, Lertmaharit S. Effectiveness of a self-management support program for Thais with type 2 diabetes: evaluation according to the RE-AIM framework. Nurs Health Sci 2015; 17: 362-69.</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main" xml:id="_z6CpQd7">Randomized, open-label, parallel group study to evaluate the effect of internet-based glucose management system on subjects with diabetes in China</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rk2fWWW">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="666" to="674" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kim HS, Sun C, Yang SJ, et al. Randomized, open-label, parallel group study to evaluate the effect of internet-based glucose management system on subjects with diabetes in China. Telemed J E Health 2016; 22: 666-74.</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main" xml:id="_ahTAJJT">Impact of remote management of diabetes via computer: the 360 study-a proof-ofconcept randomized trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Leichter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bowman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Adkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jelsovsky</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2012.0323</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ggShS7q">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="434" to="438" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leichter SB, Bowman K, Adkins RA, Jelsovsky Z. Impact of remote management of diabetes via computer: the 360 study-a proof-of- concept randomized trial. Diabetes Technol Ther 2013; 15: 434-38.</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main" xml:id="_VBqz9dk">Impact of a comprehensive digital health programme on HbA 1c and weight after 12 months for people with diabetes and prediabetes: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mcleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Signal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WJ95krU">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2559" to="2570" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McLeod M, Stanley J, Signal V, et al. Impact of a comprehensive digital health programme on HbA 1c and weight after 12 months for people with diabetes and prediabetes: a randomised controlled trial. Diabetologia 2020; 63: 2559-70.</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main" xml:id="_gzsnSAH">Successful delivery of diabetes self-care education and follow-up through eHealth media</title>
		<author>
			<persName><forename type="first">D</forename><surname>Pacaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Downey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chiasson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jcjd.2012.08.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3su5tKe">Can J Diabetes</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="257" to="262" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pacaud D, Kelley H, Downey AM, Chiasson M. Successful delivery of diabetes self-care education and follow-up through eHealth media. Can J Diabetes 2012; 36: 257-62.</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main" xml:id="_ymxbWpf">Web-based collaborative care for type 2 diabetes: a pilot randomized trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ralston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hoath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cheadle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Goldberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kCyTQJv">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="234" to="239" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ralston JD, Hirsch IB, Hoath J, Mullen M, Cheadle A, Goldberg HI. Web-based collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes Care 2009; 32: 234-39.</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main" xml:id="_zdY5h69">Randomised-controlled trial of a web-based dietary intervention for patients with type 2 diabetes: changes in health cognitions and glycemic control</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ramadas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cky</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Oldenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hussein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Quek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UXTemcb">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">716</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ramadas A, Chan CKY, Oldenburg B, Hussein Z, Quek KF. Randomised-controlled trial of a web-based dietary intervention for patients with type 2 diabetes: changes in health cognitions and glycemic control. BMC Public Health 2018; 18: 716.</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main" xml:id="_R2GbnVJ">Online disease management of diabetes: engaging and motivating patients online with enhanced resources-diabetes (EMPOWER-D), a randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Overhage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MEXuCe5">J Am Med Inform Assoc</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="526" to="534" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tang PC, Overhage JM, Chan AS, et al. Online disease management of diabetes: engaging and motivating patients online with enhanced resources-diabetes (EMPOWER-D), a randomized controlled trial. J Am Med Inform Assoc 2013; 20: 526-34.</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main" xml:id="_YqeFKSF">Web-based telemedicine for management of type 2 diabetes through glucose uploads: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chen</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9QuJXz7">Int J Clin Exp Pathol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="8848" to="8854" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhou P, Xu L, Liu X, Huang J, Xu W, Chen W. Web-based telemedicine for management of type 2 diabetes through glucose uploads: a randomized controlled trial. Int J Clin Exp Pathol 2014; 7: 8848-54.</note>
</biblStruct>

<biblStruct xml:id="b97">
	<monogr>
		<ptr target="https://datahelpdesk.worldbank.org/knowledgebase/articles/906519" />
		<title level="m" xml:id="_bgKtacH">World Bank country and lending groups country classification</title>
		<imprint>
			<publisher>The World Bank</publisher>
			<date type="published" when="2021-11-11">Nov 11, 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The World Bank. World Bank country and lending groups country classification. https://datahelpdesk.worldbank.org/knowledgebase/ articles/906519 (accessed Nov 11, 2021).</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main" xml:id="_eAsRs4U">A comparison of usability factors of four mobile devices for accessing healthcare information by adolescents</title>
		<author>
			<persName><forename type="first">B</forename><surname>Sheehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Tiase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schnall</surname></persName>
		</author>
		<idno type="DOI">10.4338/aci-2012-06-ra-0021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_s9cRwZH">Appl Clin Inform</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="356" to="366" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sheehan B, Lee Y, Rodriguez M, Tiase V, Schnall R. A comparison of usability factors of four mobile devices for accessing healthcare information by adolescents. Appl Clin Inform 2012; 3: 356-66.</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main" xml:id="_5qPdnkv">A comparison of mobile and fixed device access on user engagement associated with women, infants, and children (WIC) online nutrition education</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Brusk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Bensley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BXpdqFB">JMIR Res Protoc</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e216</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brusk JJ, Bensley RJ. A comparison of mobile and fixed device access on user engagement associated with women, infants, and children (WIC) online nutrition education. JMIR Res Protoc 2016; 5: e216.</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main" xml:id="_Fh7kgGr">Clinical-and costeffectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.1097/md.0000000000000312</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VUQbdxp">Medicine</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page">e312</biblScope>
			<date type="published" when="2014">2014</date>
			<pubPlace>Baltimore</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhai YK, Zhu WJ, Cai YL, Sun DX, Zhao J. Clinical-and cost- effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore) 2014; 93: e312.</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main" xml:id="_M9wVtfz">Effectiveness of short message service intervention to improve glycated hemoglobin control and medication adherence in type-2 diabetes: a meta-analysis of prospective studies</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pmFD9Yn">Prim Care Diabetes</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="356" to="363" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhuang Q, Chen F, Wang T. Effectiveness of short message service intervention to improve glycated hemoglobin control and medication adherence in type-2 diabetes: a meta-analysis of prospective studies. Prim Care Diabetes 2020; 14: 356-63.</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main" xml:id="_ATPTYjF">A systematic review and meta-analysis of interventions for weight management using text messaging</title>
		<author>
			<persName><forename type="first">G</forename><surname>Siopis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Allman-Farinelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EcMGTWH">J Hum Nutr Diet</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">suppl 2</biblScope>
			<biblScope unit="page">100</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siopis G, Chey T, Allman-Farinelli M. A systematic review and meta-analysis of interventions for weight management using text messaging. J Hum Nutr Diet 2015; 28 (suppl 2): 1-15. 100</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main" xml:id="_RDuRXYh">The need to improve access to dietetic services for people with type 2 diabetes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Siopis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_prCKypR">Health Promot J Austr</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siopis G. The need to improve access to dietetic services for people with type 2 diabetes. Health Promot J Austr 2022; 33: 909-11. 101</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main" xml:id="_UtPAbz2">Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?</title>
		<author>
			<persName><forename type="first">G</forename><surname>Grégoire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Derderian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Lorier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wvrNHqg">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page">102</biblScope>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grégoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995; 48: 159-63. 102</note>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main" xml:id="_7G32aZJ">Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Divers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Isom</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2021.11165</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_c4Cz2Jf">JAMA</title>
		<imprint>
			<biblScope unit="volume">326</biblScope>
			<biblScope unit="page">103</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lawrence JM, Divers J, Isom S, et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA 2021; 326: 717-27. 103</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main" xml:id="_fFcNnes">A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.3945/an.116.014100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VHsNnun">Adv Nutr</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">104</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang Y, Xue H, Huang Y, Huang L, Zhang D. A systematic review of application and effectiveness of mHealth interventions for obesity and diabetes treatment and self-management. Adv Nutr 2017; 8: 449-62. 104</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main" xml:id="_kkkP2uQ">Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Min</forename><forename type="middle">J</forename><surname>Khuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wgdBzcV">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">105</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang Y, Min J, Khuri J, et al. Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews. JMIR Mhealth Uhealth 2020; 8: e15400. 105</note>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main" xml:id="_ZyK6rrC">The effectiveness of selfmanagement of hypertension in adults using mobile health: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hesketh</surname></persName>
		</author>
		<idno type="DOI">10.2196/17776</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G3kSEaP">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">106</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li R, Liang N, Bu F, Hesketh T. The effectiveness of self- management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR Mhealth Uhealth 2020; 8: e17776. 106</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main" xml:id="_YMPtkEh">Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Monahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nickless</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YDFczbK">Hypertension</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page">107</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Monahan M, Jowett S, Nickless A, et al. Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension 2019; 73: 1231-39. 107</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main" xml:id="_fK7h6VN">Telemedicine cost-effectiveness for diabetes management: a systematic review</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Swh</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_abGvmFY">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">108</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee JY, Lee SWH. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 2018; 20: 492-500. 108</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main" xml:id="_hh4d5EM">Cost and costeffectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review</title>
		<author>
			<persName><forename type="first">G</forename><surname>Rinaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hijazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Haghparast-Bidgoli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uFtwhxR">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="108084" to="108109" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rinaldi G, Hijazi A, Haghparast-Bidgoli H. Cost and cost- effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract 2020; 162: 108084. 109</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main" xml:id="_xzf35d9">The dietetic workforce distribution geographic atlas provides insight into the inequitable access for dietetic services for people with type 2 diabetes in Australia</title>
		<author>
			<persName><forename type="first">G</forename><surname>Siopis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Allman-Farinelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X6pYKJh">Nutr Diet</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="121" to="130" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siopis G, Jones A, Allman-Farinelli M. The dietetic workforce distribution geographic atlas provides insight into the inequitable access for dietetic services for people with type 2 diabetes in Australia. Nutr Diet 2020; 77: 121-30.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
